3193 instruction ru e411
TRANSCRIPT
-
7/23/2019 3193 Instruction RU e411
1/379
cobas e411 analyzer"$%'%()+'%%,-/+%/
-
7/23/2019 3193 Instruction RU e411
2/379
-
7/23/2019 3193 Instruction RU e411
3/379
cobas e 411 /1/234/+%
5"$%'%()+'%,%274%'/+-28
!"$%')++,./"'02.01-01
-
7/23/2019 3193 Instruction RU e411
4/379
cobas e 411 /1/234/+%
9)+%3834:-1-13;
4)6"',
7,$,7)/
"$&()$*,-/-0&1/2"$&()4256-72 8212$"/(9((:9;"7"7()
1.0 3
, ?-;"$92,292
A7C6(D&,(D 0490 5148 018
!#%&')*+, 0490 5148 080
-/1/&*+, 0490 5148 001
23#45%6*+, 0490 5148 050
8:!3'
-
7/23/2019 3193 Instruction RU e411
5/379
cobas e 411 /1/234/+%
H))%/"%0%/J"%
=#&+/%3#1+, :3*!D3+B+/+4+!#)!#E:3*+4/*#!63?/%%DK=!/=#!#3:?, #3#*G/@4B
4MEDK3/63:?4+E:=!+1/%/%+,6?B)#%%DK6?/3/!+%#!+/,, =+H/,, ?:@:,+4+
:*!'G#MH/,6!/@:,.
US Pat. 5,147,806; US Pat. 5,779,976; US Pat. 6,325,973; US Pat. 5,466,416; US Pat.
5,624,637; US Pat. 5,720,922; US Pat. 5,061,445; US Pat. 5,068,088; US Pat. 5,247,243; US
Pat. 5,296,191, +6::3?/363?'MH+/=#3/%3D?@!'%:/?38
Q')27/)
-
7/23/2019 3193 Instruction RU e411
6/379
cobas e 411 /1/234/+%
-
7/23/2019 3193 Instruction RU e411
7/379
@%(-B/13-
263:!+B+)1/%/%+, 2 7 @,-?3/271C-%,-/?33: =/$
\:%3#*3%#B+%F:!1#&+B 3 IE):! B-93
Z:@/!G#%+/ 5 \#* +6=:45):?#35 N3!+K-*:@ R3+*/3*+ @4B=!:E+!:*+/1*:63/, B-94
IE):! 7 \#*)#
h@/+6*#35+%F:!1#&+M 7 \#*?DE!#35:@+%+4+E:4//
Z+63/1#2%3/!#*3+?%:,8:1:H+ 8 :E!#)&:??IE):!/>#%%DK B-98
2%F:!1#&+B@4B)#*#)A+*# 9 \#*#!K?+!:?#35@#%%D/=::E!#) B-99
9 \#*=:?3:!B35#%#4+):E!#) B-100Z:*!#H/%+B, +6=:45)'/1D/?!'*:?:@63?/ Z+63/1%D,6E!:6 B-101
D,3)/13-)3)+-:C F/)+7A \#*'@#4+35/@+%+A%D,:3*!D3D,)#=!:6B-103\#*%#)%#A#35=:)+&++*#4+E!#3:!:?+*:%3!:4/,
B-104 \#*'cn%#?4+?#35+:=!/@/4B35
*:%3 :4+RocheB-106
1 91>%:/?38,%G-4%,/)1%)+3 \#*'63#%#?4+?#35+:=!/@/4B35%/-Roche *:%3!:4+B-107
\4#66+F+*#&+B1/!E/):=#6%:63+ A-5 \#*!/@#*3+!:?#35)%#A/%+B*:%3!:4/, B-109
]/!D=!/@:63:!:G%:63+ A-5 \#*)#=!:6+35QC E'3D4*+?!/G+1/:G+@#%+B
B-110
b3+*/3*+=:E/):=#6%:63+?6+63/1/ A-18 \#*:31/%+35)#@#%+/%#=/A#35 B-111
\#*!#6=/A#3#35/G/@%/?%D,:3A/3
I364/G+?#%+/Z+
DG)2"B3'/13- F/)+7C
I6%:?D=!:
-
7/23/2019 3193 Instruction RU e411
8/379
cobas e 411 /1/234/+%
10 91>%:/?3%11C- )3L1/271C-)%%GM-138
T?/@/%+/ D-33
Z=+6:*+%F:!1#&+:%%DK6+
-
7/23/2019 3193 Instruction RU e411
9/379
cobas e 411 /1/234/+%
DG4%)3)+-:C
V%#4+)#3:!cobas e 411 Roche Diagnostics cobas e 411 R3:=:4%:635M
#?3:1#3+A/6*#B, =!:+)?:45%:
+11'%:4:
1:@'4B'=!#?4/%+B, *:3:!D,*:%3!:4+!'/3#%#4+)#3:!6=:1:H5M
=:45):?#3/456*:, =!:
'A+3D?#B, A3:=!:E+!*+6:E!#)+6%#EG/%DN3!+K-*:@#1+ +=!:@:4G#/36B
?=4:35@:R4/*3!:K/1+4M1+%+6&/%3%:_#*G/, =!:
b3:!'*:?:@63?:6:@/!G+3@/3#45%:/:=+6#%+/F'%*&+,+:EH+K*:%&/=&+,
!#E:3D6#%#4+)#3:!:1cobas e 411, 6=/&+F+*#&++, ++%F:!1#&+M=:
+6=:45):?#%+M*:%3!:4/,, 3/K%+*/:=/!+!:?#%+B, R*63!/%%D1=!:&/@'!#1,
1#!*+!:?*/=!:@'*3#+=!:&/@'!#1:E64'G+?#%+B.
U',+2%"W%)'J$)/)
>+%"',$%2/+,.:)6)[?
2%F:!1#&+B, *:3:!#B1:G/3?#1=:%#@:E+356B@4B!#E:3D6#%#4+)#3:!:1
cobas e 411, =:63#?4B/36B?%/6*:45*+K=/A#3%DK+R4/*3!:%%DK='E4+*#&+BK.
P'*:?:@63?:I=/!#3:!#6:@/!G+3+%F:!1#&+M:E/):=#6%:63+, #==#!#3%DK
6:63#?4BMH+K6+63/1D, !#E:3/66+63/1:,, #3#*G/:=+6#%+/:E64'G+?#%+B+
!/N/%+B?:)1:G%DK=!:E4/1. _#E4+:@/!G#%+B?%#A#4/!'*:?:@63?# +?
%#A#4/*#G@:,
F'%*&+,R4/*3!:%%:
-
7/23/2019 3193 Instruction RU e411
10/379
cobas e 411 /1/234/+%
L',%$2T
0:',/)9+2$
COBI-CD
_#*G/?R3:1!'*:?:@63?/+1//36B\!#3*+,Z=!#?:A%+*. b3:3%/E:45N:,
@:*'1/%3@:=:4%B/3!'*:?:@63?::=/!#3:!#+6:@/!G+3+%F:!1#&+M :3:1,
A3:?3:A%:63+%'G%:@4B!#E:3D6#%#4+)#3:!:1, %:E/)'!:?%B@/3#4+)#&++
P'*:?:@63?#.
COBI-CD (Z:E!#%+/?6=:1:
:3%:6BH+,6B*R3:,:E4#63+=!+4:G/%+B. 2%3/!#*3+?%#B=:1:H5=!/@4#
+6=:45)',3/)#*4#@*+6:@/!G#%+/, +%@/*6+4+=:+6*@4B%#K:G@/%+B
%#+E:4//E4+)*:,*+6*:1:,+%F:!1#&++.
-
7/23/2019 3193 Instruction RU e411
11/379
cobas e 411 /1/234/+%
91>%:/?38(284/$/4Q3$/
\XJ9"+2"7,$,792$, Z?BG+3/656?#N+14:*#45%D1=!/@63#?+3/4/1Roche =:4MED1?:=!:6#1,
*#6#MH+16B:E'A/%+B6+63/1/#%#4+)#cobas e 411 +4+1#3/!+#4:?@4B:E'A/%+B.
L)+%,$%0$!2"+%0$260"'/20)6 Z?BG+3/656?#N+14:*#45%D1=!/@63#?+3/4/16/!?+6#Roche @4B=:4'A/%+B
@#45%/,N/,+%F:!1#&++=:6/!?+6%:1'6:+^)'6,=2.:)7,$,7J a#63+@4B)#1/%D, 1#3/!+#4D,!/#
-
7/23/2019 3193 Instruction RU e411
12/379
cobas e 411 /1/234/+%
@XX'"/2,%J'E 26=:45)'M36B64/@'MH+/#EE!/?+#3'!D:
RGG-'3/+"/ 5/)J3>%'$/
A
ANSI
C
CBT
CCITT
CE
CLAS 2
CLIA
COBI-CD
CSA
DdBA
DIL
E
EC
ECL
EMC
EN
F
FIFO
HHCFA
I
IEC
IVD
K
KVA
L
LDL
LISM
MSDS
N
NCCLS
P
PC/CC
Q
QC
-#&+:%#45%D,+%63+3'363#%@#!3+)#&++ZdV
IE'A/%+/6=:1:H5M*:1=5M3/!#
(ComitkConsultatif International de Tklkgraphique et Tklkphonique
, Consultative Committee for International Telegraph and
Telephone) ]\\__(=!/G%//%#)?#%+/\:%6'453#3+?%:
ZE:!%+*?6=:1:
-
7/23/2019 3193 Instruction RU e411
13/379
cobas e 411 /1/234/+%
RGG-'3/+"/ D,-(-2-13-
S
SD Z3#%@#!3%:/:3*4:%/%+/
S/R IE!#)/&/!/#
*:%F+
-
7/23/2019 3193 Instruction RU e411
14/379
cobas e 411 /1/234/+%
-
7/23/2019 3193 Instruction RU e411
15/379
D,3)/13-)3)+-:C
1 >+^)'6,=2.:)X"7):,0+)0%2 .......................................... A-3
2 \X7)'020%"6E .................................................................... A-25
3 `)
-
7/23/2019 3193 Instruction RU e411
16/379
-
7/23/2019 3193 Instruction RU e411
17/379
Roche DiagnosticsA-3 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
91>%:/?38,%G-4%,/)1%)+3
8/!/@%#A#4:1!#E:3D6#%#4+)#3:!:1cobas e 411, ?#G%:=!:A+3#35+=:%B35
=!/@'=!/G@/%+B+!/*:1/%@#&++=:E/):=#6%:63+, 6:@/!G#H+/6B?R3:1
!'*:?:@63?/.
Z4/@'MH+/1/!D=!/@:63:!:G%:63+++%63!'*&++=!/@%#)%#A/%D@4B
:=/!#3:!:?+@4B?6/K:3?/363?/%%DK)#'=!#?4/%+/#%#4+)#3:!:1.
TV+%;L2/'- !"$"
\4#66+F+*#&+BE/):=#6%:63+ ................................................................................... 5
]/!D=!/@:63:!:G%:63+ ......................................................................................... 5
8!/@'=!/G@/%+B ................................................................................................. 5
C+:4:
P#6=:4:G/%+/R3+*/3:*=:E/):=#6%:63+%#1:@'4/#%#4+)#3:!#(@+6*:?#B6+63/1#) ....................................................................................................... 19
P#6=:4:G/%+/R3+*/3:*=:E/):=#6%:63+%#1:@'4/#%#4+)#3:!#(N3#3+?%#B
6+63/1#) ....................................................................................................... 20
P#6=:4:G/%+/R3+*/3:*=:E/):=#6%:63+%#=:@@:%/@4B3?/!@DK:3K:@:?+
)#1/%B/1:1?*4#@DN/ ................................................................................. 21
263:A%+*=+3#%+B ............................................................................................ 22
_'1E4/!=+3#%+B ........................................................................................ 22
_'1E4/!D=+3#%+BN3#3+?%:
-
7/23/2019 3193 Instruction RU e411
18/379
Roche DiagnosticsA-4 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
-
7/23/2019 3193 Instruction RU e411
19/379
Roche DiagnosticsA-5 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
L!,002 2$,=2.X"7):,0+)0%2
=2/))3>3$/?38G-4%,/)1%)+3
b3#6/*&+B=:B6%B/3, *#*=!/@'=!/G@#MH#B+%F:!1#&+B'*#)D?#/36B?
!'*:?:@63?/.
e T@#%%:1!'*:?:@63?/, )%#*+E/):=#6%:63++6=:45)'M36B@4B=!+?4/A/%+B?#N/
-
7/23/2019 3193 Instruction RU e411
20/379
Roche DiagnosticsA-6 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`"'E:'"
K%L1"+/8323,%'-B(-11/82%,/)+7:3$%J/3$%'%L%:3$)-/
4"0D2X,T%"62$0"'/)/'"6.)920%$2.d0!262$0"':)/'"7X"D,T%" :'.6)D) $)+%,$%, 0 '",D"+%,62 2 )92[,P[262 ',0%/)',62. H!"
!PX)"/'"6..
-
7/23/2019 3193 Instruction RU e411
21/379
Roche DiagnosticsA-7 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`"'E:'"
W%2$"%$)T.4")%$'E/,T%"7,7):'):2!)/ET,!$)D)!?2 W%,+)! (70%)./!.P%0.D)'P9262/"["0%/,62,
226""%0.):,0+)0%?/)7+2$+)/"+2.:)b,',, /7'E/, 2!2:)!J9"+2.)b)D)/.
-
7/23/2019 3193 Instruction RU e411
22/379
Roche DiagnosticsA-8 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`"'E:'"+,9",6)DJ%XE%?:)!J9"+E+"%)9+E"
\0J["0%/!.T%" :',/2!?+)" )X0!Jb2/,+2" 020%"6E
-
7/23/2019 3193 Instruction RU e411
23/379
Roche DiagnosticsA-9 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`"'E:'"
-
7/23/2019 3193 Instruction RU e411
24/379
Roche DiagnosticsA-10 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`"'E:'"3$/?38%,-/+%/
4"/E:)!+.T%"):"',=222)X0!Jb2/,+2"020%"6E, "0!2/E+"XE!20:"=2,!?+))XJ9"+E
,/%)'27)/,++E6:"'0)+,!)6Roche Diagnostic.N+26,%"!?+)0!"
:"'0)+,!,Roche..H!"
4"$)''"$%+)276"'"++ET'"7J!?%,%6)b"%:'2/"0%2$)_2X)9+)T Q')/"'?%", 9%)276"'"+2.$)+%')!.$,9"0%/,+,Y)
',X)%E.
O/:-1/-/L-1+1CY$/))-+
>+0%'J6"+%
-
7/23/2019 3193 Instruction RU e411
25/379
Roche DiagnosticsA-11 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`"'E:'"
9),/-13-%G/4?/
d0!2)X',7"=XE!+,X)'%J2+0%'J6"+%,X)!""0:,'"+2")X',7=)/, $)%)'E"XE!2+,X)'%JX)!""
0X2)):,0+E626,%"'2,!,62.
H!"
-
7/23/2019 3193 Instruction RU e411
26/379
Roche DiagnosticsA-12 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`"'E:'"
)%Y)
/,_"T$)b"T, :'26"+2%" N0"D
H)X!P
d0!2$,$)T-!2X)X2)!)D29"0$2):,0+ET6,%"'2,!)$,b"%0.+,/,_"T$)b", +"6"
K-(%)+--B-138
R2P:313-'C-Q/)+3
4"20:)!?7JT%"$20!)%+E"2!2,!$,!2+)/E"',0%/)'E
-
7/23/2019 3193 Instruction RU e411
27/379
Roche DiagnosticsA-13 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`"'E:'"
-
7/23/2019 3193 Instruction RU e411
28/379
Roche DiagnosticsA-14 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`"'E:'"
-
7/23/2019 3193 Instruction RU e411
29/379
Roche DiagnosticsA-15 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`"'E:'"
4"20:)!?7JT%")'D,+29"0$2"',0%/)'2%"!2, $')6"27):'):2!)/)D),!$)D)!.2!2
W%,+)!,
b%+%-)-1)%C
fJ
-
7/23/2019 3193 Instruction RU e411
30/379
Roche DiagnosticsA-16 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`"'E:'"+,9", /E6)b"%":)!J92%?%',/6J.
Q')/"'?%", 9%)9"Y)!')%)','",D"+%)/7,$'E%/)/'"6.',X)%E, "0!2/E+"7,6"+."%"
'",D"+%E.d0!2$'E_$,XJ
0))X["+2".
8,$'E/,T%"[2%)$02::"',:)0!"7,6"+E020%"6+)D)'",D"+%,2!2/E:)!+"+2.
)X0!Jb2/,+2., 2+,9"2+0%'J6"+%+"+,9+"%',X)%J.
K%+-Q$3
4"6"
'"$)6"+
-
7/23/2019 3193 Instruction RU e411
31/379
Roche DiagnosticsA-17 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`"'E:'"
-
7/23/2019 3193 Instruction RU e411
32/379
Roche DiagnosticsA-18 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`,'$2')/$2X"7):,0+)0%2/020%"6"
H/$3%'$3G-4%,/)1%)+3')3)+-:-
8!/@'=!/G@#MH+/R3+*/3*+!#)1/H/%D?6+63/1/, A3:ED=!+?4/A5?#N/?%+1#%+/*
=:3/%&+#45%::=#6%D1:E4#63B1. b3+*/3*+++K:=+6#%+/=/!/A+64/%D%+G/, ?
6::3?/363?++6:E4#63B1+?6+63/1/,
b3#R3+*/3*#'*#)D?#/3, A3:+1//36B?/!:B3%:635
?:)%+*%:?/%+B:=#6%DK6+3'#&+,?E4+)+1/63#!#6=:4:G/%+BR3+*/3*+, *:3:!D/1:
=!#?+4#E/):=#6%:63+.
K-(",-B(-13-: :-Y/13Q-)$3-Q/)+3
b3+*/3*#'*#)D?#/3, A3:?:E4#63++1//36B:=#6%:635*:%3#*3#6
@?+G'H+1+6B1/K#%+A/6*+1+A#63B1+.
=%%43;1C-:/+-3/2C
b3#R3+*/3*#'*#)D?#/3, A3:?E4+)+//!#6=:4:G/%+B
%/:EK:@+1:=:45):?#356B)#H+3%D1+:A*#1++
=/!A#3*#1+, 3#**#*+1//36B:=#6%:635
*:%3#*3+!:?#%+B6*:!!:)+,%D1+1#3/!+#4#1+.
STAT %3-1+/?38J+/+3'/
QFdc\HBdFdjd4>d:Q'2J0%,+)/$"STAT
_%,%2/,, :')/"'?%""D)+,:',/!"+2".
b3#R3+*/3*#6:@/!G+3=!/@'=!/G@/%+/, A3:
N3#3+?D@:4G%D=:1/H#356B?STAT (\:!:3*:
-
7/23/2019 3193 Instruction RU e411
33/379
Roche DiagnosticsA-19 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`,'$2')/$2X"7):,0+)0%2/020%"6"
K%2%B-13-V+3$-+%$G-4%,/)1%)+31/:%("2-/1/234/+%/((3)$%'/8)3)+-:/)
8!/@'=!/G@#MH+/R3+*/3*+=!+*!/=4BM36B%#+%63!'1/%3?64/@'MH+K=:)+&+BK:
53). A-1 "$&')'*+-.+/1.2+1'23+4'&"$-'$1.:5'67)9"-").4"1':"(6.$2'
-
7/23/2019 3193 Instruction RU e411
34/379
Roche DiagnosticsA-20 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`,'$2')/$2X"7):,0+)0%2/020%"6"
K%2%B-13-V+3$-+%$G-4%,/)1%)+31/:%("2-/1/234/+%/(J+/+3'1/8)3)+-:/)
8!/@'=!/G@#MH+/R3+*/3*+=!+*!/=4BM36B%#+%63!'1/%3?64/@'MH+K=:)+&+BK:
53). A-2 "$&')'*+-.+/1.2+1'23+4'&"$-'$1.:5'67)9"-").4"1':"(>1"1.
-
7/23/2019 3193 Instruction RU e411
35/379
Roche DiagnosticsA-21 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`,'$2')/$2X"7):,0+)0%2/020%"6"
K%2%B-13-V+3$-+%$G-4%,/)1%)+31/,%((%1-(28+'-(CY%+Y%(%'3):-11%:'$2/(CJ-
8!/@'=!/G@#MH+/R3+*/3*+=!+*!/=4BM36B**:%3/,%/!'@4B3?/!@DK:3K:@:?
+61/%%D1?*4#@DN#1?64/@'MH+K=:)+&+BK.
53). A-3 "$&')'*+-.+/1.2+1'23+4'&"$-'$1.: &'66'-6)=1
-
7/23/2019 3193 Instruction RU e411
36/379
Roche DiagnosticsA-22 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e 411 /1/234/+%
`,'$2')/$2X"7):,0+)0%2/020%"6"
9)+%Q13$,3+/138
H-C,%V2-$+3Q-)$%;G-4%,/)1%)+3
4":'"
Z4/@'MH+,!+6'%:*=:*#)D?#/33'1E4/!=+3#%+B+*#E/45=+3#%+B.
53). A-4 "$&')'*+-.+/1.2+12.3+4'&"$-'$1.: 1753)+:'$-'
-
7/23/2019 3193 Instruction RU e411
37/379
Roche DiagnosticsA-23 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 1 91>%:/?38,%G-4%,/)1%)+3
`,'$2')/$2X"7):,0+)0%2/020%"6"
[":G2-,3+/138J+/+3'1%L%G2%$/,--1%)$3%G/4?%'
Z4/@'MH+,!+6'%:*=:*#)D?#/33'1E4/!=+3#%+BN3#3+?%:
-
7/23/2019 3193 Instruction RU e411
38/379
Roche DiagnosticsA-24 5"$%'%()+'%%,-/+%/ T-)381.0
1 91>%:/?38,%G-4%,/)1%)+3 cobas e411 /1/234/+%
`,'$2')/$2X"7):,0+)0%2/020%"6"
-
7/23/2019 3193 Instruction RU e411
39/379
Roche DiagnosticsA-25 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
DG4%)3)+-:C
b3#
-
7/23/2019 3193 Instruction RU e411
40/379
Roche DiagnosticsA-26 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
]:@'45'=!#?4/%+B ......................................................................................... 44
]#!*+!:?*#*:%3/,%/!#%#E:!#!/#
-
7/23/2019 3193 Instruction RU e411
41/379
Roche DiagnosticsA-27 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
\X7)',+,!27,%)',cobas e 411
DG4%/1/234/+%/cobas e 411
211'%:4:
Z+63/1#6:63:+3+)#%#4+)#3:!#, *:3:!D,?D=:4%B/3?6/F'%*&++%/:EK:@+1D/
@4B=:4%:,#?3:1#3+)#&++:E!#E:3*+:E!#)&:?+#%#4+):?, +1:@'4B
'=!#?4/%+B, *:3:!D,'=!#?4B/3#%#4+)#3:!:1A/!/)=:45):?#3/456*:/
=!:
:=!/@/4/%+BECL, +=/!/@#A'!/)'453#3:?.
8!:
!/)'453#3D, 6:)@#/3@:*'1/%3#&+M+?D=:4%B/3*:%3!:45*#A/63?#. _#*G/,
=!:
=!+6:/@+%/%%D1Pre-Analytic Systems Manager (PSM)(1)+#%#4+)#3:!:1cobas e
41. -/6*:45*:#%#4+)#3:!:?l cobas e 4111:
-/:EK:@+1:635!'A%:
-
7/23/2019 3193 Instruction RU e411
42/379
Roche DiagnosticsA-28 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
\X7)',+,!27,%)',cobas e 411
^3)$%'C-3J+/+3'1C-)3)+-:C
V%#4+)#3:!cobas e 411@:63'=/%?*#A/63?/@+6*:?:,+N3#3+?%:,6+63/1D.
P#)4+A+B1/G@'@?'1B*:%F+
-
7/23/2019 3193 Instruction RU e411
43/379
Roche DiagnosticsA-29 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
\X7)',+,!27,%)',cobas e 411
^3)$%'/8)3)+-:/
Z4/@'MH+,!+6'%:*=:*#)D?#/3@+6*:?'M6+63/1'#%#4+)#3:!#cobas e411:
53). A-6 cobase 411 (6.$2'
-
7/23/2019 3193 Instruction RU e411
44/379
Roche DiagnosticsA-30 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
L)6:)+"+%E020%"6E
=%:,%1-1+C)3)+-:C
b3#
-
7/23/2019 3193 Instruction RU e411
45/379
Roche DiagnosticsA-31 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
`)
-
7/23/2019 3193 Instruction RU e411
46/379
Roche DiagnosticsA-32 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
`)
-
7/23/2019 3193 Instruction RU e411
47/379
Roche DiagnosticsA-33 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
`)
-
7/23/2019 3193 Instruction RU e411
48/379
Roche DiagnosticsA-34 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
`)4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++61. h4#?'3 ]:@'45j=!#?4/%+B.
53). A-11 K'67)97&:"
-
7/23/2019 3193 Instruction RU e411
49/379
Roche DiagnosticsA-35 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
L)6:)+"+%E020%"6EW!"$%'):2%,+2.
5/G%Q3;,--$2PQ/+-27,3+/138
P#E:A+,=/!/*4MA#3/45=+3#%+B!#6=:4:G/%%#%+G%/,4/?:,=/!/@%/,
63:!:%/#%#4+)#3:!#. 26=:45)',3/!#E:A+,=/!/*4MA#3/45 @4B?D*4MA/%+B
#%#4+)#3:!#6&/45M?D=:4%/%+B:=!/@/4/%%DK=!:&/@'!:E64'G+?#%+B, +4+
/64+6+63/1#%/+6=:45)'/36B?3/A/%++'?/4+A/%%DK=/!+:@:??!/1/%+(%#=!+1/!, ?3/A/%++%:A+). P#E:A+,=/!/*4MA#3/45=+3#%+B3#*G/?D*4MA#/3
=+3#%+/6/%6:!%:
-
7/23/2019 3193 Instruction RU e411
50/379
Roche DiagnosticsA-36 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
L)6:)+"+%E020%"6EW!"$%'):2%,+2.
A O753)+:&.1"-.=
53). A-13 O753)+:&.1"-.=
B Q"3+)9&.1"-.=
[":G2-,3+/138J+/+3'1%L%G2%$/
-#4/?:,63:!:%/N3#3+?%:
-
7/23/2019 3193 Instruction RU e411
51/379
Roche DiagnosticsA-37 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
H:"=2^2$,=22020%"6E
@,-?3>3$/?33)3)+-:C
[-Y13Q-)$/831>%:/?38
8#%/45,!#6=:4:G/%%#B%#=!#?:,63:!:%/#%#4+)#3:!#, 6:@/!G+3%:1/!
A#63+, 6/!+,%D,%:1/!+3!/E:?#%+B*R4/*3!:=+3#%+M.
Z4/@'MH+,!+6'%:*=!/@63#?4B/36:E:,=!+1/!3#*:,=#%/4+#%#4+)#3:!#.
53). A-15 V:.5+:&"-+)."-").4"1':"
5/4:-C31)+":-1+/
Z4/@'MH#B3#E4+:@/!G+3!#)1/!D#%#4+)#3:!#cobas e 411, *#*@4B
@+6*:?:,, 3#*+@4BN3#3+?%:,6+63/1D:
R1/234/+% TC)%+/ N2"G31/ e331/ TC)%+/
31.4@(a)
80 61
(a)
(43 @, 109 616:3*!D3:,?/!K%/,*!DN*:,)31.4 @(a)80 61(a)
(43 @+4+109 61Z:3*!D3:,?/!K%/,*!DN*:,)
28.7 @73
6137.4 @(b)
95 61(b)
47.2 @
120 6167 @170
61
397 F
180 *
-
7/23/2019 3193 Instruction RU e411
52/379
Roche DiagnosticsA-38 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
H:"=2^2$,=22020%"6E
_2-$+3Q-)$3-),-?3>3$/?33
Z4/@'MH#B3#E4+=/!/A+64B/33!/E:?#%+M*R4/*3!:=+3#%+M+
3/=4:?D@/4/%+M#%#4+)#3:!#cobas e 411:
_!/E:?#%+B*'63#%:?*/: 2%63!'1/%36:?1/63+163!/E:?#%+B1=:E/):=#6%:63+IEC 61010-1, 2B!/@#*&+B; IEC 61010-
2-081, 1B!/@#*&+B; IEC 61010-2-101, 1B!/@#*&+B;
UL 61010-1, 2B!/@#*&+B; CAN/CSA C22.2 No.
61010-1:2004. Z3/=/%5)#
\#3/
-
7/23/2019 3193 Instruction RU e411
53/379
Roche DiagnosticsA-39 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
H:"=2^2$,=22020%"6E
TD@/4/%+/3/=4#(=!+1/!%:):
2879 kJ/hresp.
688 kcal/hresp.
2730 Btu/h
3778 kJ/hresp. (d3#3+?%D,1:@'45: 899 kJ/hr resp)903 kcal/hresp. (d3#3+?%D,1:@'45: 215 kcal/hr
resp.) 3583 Btu/h (d3#3+?%D,1:@'45: 853 Btu/hr)
[/G23?/A-2 W)+21:.E+$2.+$&+I.Y.2"I..
])2%'38%$"B/PM-;)-(C
V%#4+)#3:! cobas e 411 !#)!#E:3#% @4B +6=:45):?#%+B 3:45*: ?%'3!+
=:1/H/%+B. Z4/@'MH#B 3#E4+ 6:@/!G+3 =!+/14/1D/ @+#=#):%D =#!#1/3!:?
:*!'G#MH/, 6!/@D, =!+ *:3:!DK #%#4+)#3:!D cobas e 411 F'%*&+:%+!'M3
%#@/G%:+3:A%::
_/1=/!#3'!#: P#E:3#: 18 - 32Co!#%/%+/+3!#%6=:!3+!:?*#: -20 to 75C
2)1/%/%+/3/1=/!#3'!D:
T4#G%:635(+6=:45):?#%+/3:45*:?%'3!+=:1/H/%+B):
]#*6+1'1 2C/h
P#E:3#: 20 - 80% (*:%@/%6#&+B:36'363?'/3)
o!#%/%+/+3!#%6=:!3+!:?*#: 5- 95%
(:36'363?+/*:%@/%6#&++,
E
[/G23?/A-4 Z:'75"
-
7/23/2019 3193 Instruction RU e411
54/379
Roche DiagnosticsA-40 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
H:"=2^2$,=22020%"6E
9)+%Q13$'%(C
Z4/@'MH#B3#E4+:@/!G+33!/E:?#%+B*?:@B%:1'6%#EG/%+M:
\:%3/,%/!@4B?:@D: 34
_!/E:?#%+B*?:@/: < 10 1*Z1/61+4+> 0.1 ]I1, 6?:E:@%#B
:3E#*3/!+,(@:E#?4B/36BSysWash 6
!#)E#?4/%+/1100+1)
8:3!/E4/%+/?:@D: 3 4%#250 4+3!:?
(6!/@%//): 12 14/&+*4
[/G23?/A-5 R'6=-'+$-"3*+-.+
f3($3-%+Y%(C
\:%3/,%/!@4BG+@*+K:3K:@:?:
T1/63+1:635: 4 4, 6@/3/*3+!:?#%+/1=/!/=:4%/%+B.
[/G23?/A-6 [.62.+'1@'6?
L)+%"T+"'
2)1/!/%+/#%#4+):?: >: 86 3/63:?/ A#6
[/G23?/A-8 V:'&7$2-"=$&'$'3-'$19
@3)+-:/,--1%)$3%G/4?%'
Z4/@'MH#B3#E4+:@/!G+36=/&+F+*#&++@4B6+63/1D=/!/%:6*+:E!#)&:?.
I=!/@/4/%%D/=#!#1/3!D?1/63+1:63+?#!5+!'M36B1/G@'@+6*:?:,+
N3#3+?%:,6+63/1#1+.
-
7/23/2019 3193 Instruction RU e411
55/379
Roche DiagnosticsA-41 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 2726(921-$ 2E59-$&(&1";>
H:"=2^2$,=22020%"6E
8!+%&+=!/#
=:)+&+,
T6/
-
7/23/2019 3193 Instruction RU e411
56/379
Roche DiagnosticsA-42 5"$%'%()+'%%,-
',7'.
-
7/23/2019 3193 Instruction RU e411
57/379
Roche DiagnosticsA-43 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
H:"=2^2$,=22020%"6E
D)+/+%Q1C;%Gc-:((3)$%'/8)3)+-:/)
Z4/@'MH#B3#E4+=/!/A+64B/3:63#3:A%D/:Ei/1D@4B@4B!#)4+A%DK
?#!+#%3:?*:%3/,%/!:?:E!#)&:?. b3+&+F!D=!+1/%+1D3:45*:*
@+6*:?D16+63/1#1.
=%1+-;1-(28%G/4?%' TC)%+/,%G3$3 `%:/271/8 ]:-17J-11/8
Z3#%@#!3%#BHitachi =!:E+!*#%#@+6*/:E!#)&:?:
Z3#%@#!3%#BHitachi =!:E+!*#%#=/!?+A%:,=!:E+!*/(16 11@+#1/3!):
Z3#%@#!3%#BHitachi =!:E+!*#%#=/!?+A%:,=!:E+!*/(dia. = 16 11):
8/!?+A%#B=!:E+!*#:E!#)&:?(13 11@+#1/3!):
8/!?+A%#B=!:E+!*#:E!#)&:?(13 11@+#1/3!):
8/!?+A%#B=!:E+!*#:E!#)&:?(16 11@+#1/3!):
8/!?+A%#B=!:E+!*#:E!#)&:?(16 11@+#1/3!):
X1*:635*#4+E!#3:!#/*:%3!:44/!#:
D)+/+%Q1C;%Gc-: D)+/+%Q1C;%Gc-:
200 1*4 100 1*4
75 11 200 1*4 150 1*4
100 11 200 1*4 150 1*4
75 11 600 1*4
100 11 600 1*4
75 11 1000 1*4
100 11 1000 1*4
150 1*4(a)
[/G23?/A -10G$1"1'E-?B'3\+52'-1+B-+:"'3:"4I')X',7=)/2!2'",$=2)++,.:')X2'$,1"1.
-
7/23/2019 3193 Instruction RU e411
58/379
Roche DiagnosticsA-44 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
H:"=2^2$,=22020%"6E
N7,/2026)0%2)%)Xh"6)/)X',7=)/2%2:)/"6$)0%"T(+,:'26"', :"'/29+,.:')X2'$,
)X',7=)/2!2'",$=2)++,.:')X2'$,
H20%"6+E"'",D"+%E Z4/@'MH#B3#E4+:@/!G+36=/&+F+*#&++@4B6+63/1%DK!/#
-
7/23/2019 3193 Instruction RU e411
59/379
Roche DiagnosticsA-45 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
H:"=2^2$,=22020%"6E
94:-3+-271/8)3)+-:/
Z4/@'MH#B3#E4+:@/!G+36=/&+F+*#&++@4B+)1/!+3/45%:,6+63/1D:
2)1/!+3/45%D,1/3:@:
P/G+1*#4+E!:?*+:
ProCell =:3!/E4/%+/
CleanCell =:3!/E4/%+/
T!/1B&+*4#:
_/1=/!#3'!#:
2%3/
2-3:A/A%#B*#4+E!:?*#
8!+1/!%:2 14%#&+*4
8!+1/!%:2 14%#&+*4
42 6
28C 2C
[/G23?/A-15 J45+:.1+)9-"=$.$1+5"
H%("27",/'2-138
Z4/@'MH#B3#E4+:@/!G+36=/&+F+*#&++@4B1:@'4B'=!#?4/%+B:
_+=:
o!#%+4+H/@#%%DK:
Z+63/1%D,+%3/!F/,6:
j=!#?4BMH+,+%3/!F/,6:
T%/N%+,=!+%3/!:
]:%+3:!66/%6:!%D1R*!#%:1:
I=/!#&+:%%#B 6+63/1#
2%3/
*:11'%+*#&+:%%DK'63!:,63?('@#4/%%D,@:63'=, cobas Link)
CCITT V. 24/RS-232-C (@?'%#=!#?4/%%D,)
j=!#?4BMH#B6+63/1#@:4G%#6::3?/363?:?#353!/E:?#%+B1IEC (60950)
Z:/@%+%/%+/A/!/)USB =:!3
e >4B@#45%/,N/,+%F:!1#&+++6=+6*#!/*:1/%@'/1DK
1:@/4/,=!+%3/!#, 61.N+"_+2T:'2+%"'%#63!. A-58.
39 61(15 @) &?/3%:,TFT-LCD, XGA
Microsoft Windows XP (?63!:/%%#B:=/!#&+:%%#B6+63/1#)
[/G23?/A-16 Z&:":=:4%+3/45%'M+%F:!1#&+M61. ? h4#?/3`)
-
7/23/2019 3193 Instruction RU e411
60/379
Roche DiagnosticsA-46 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
H:"=2^2$,=22020%"6E
_+3$-+$3$%1+-;1-/1/G%/-/L-1+%'
P/#
-
7/23/2019 3193 Instruction RU e411
61/379
Roche DiagnosticsA-47 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
H:"=2^2$,=22020%"6E
5-/L-1+1C-$/))-+C
Z4/@'MH+,!+6'%:*=:*#)D?#/3=!+1/!!/#
Z/!+,%D/%:1/!#*#4+E!#3:!:?+%#)%#A/%%D/)%#A/%+B
Z!:*
-
7/23/2019 3193 Instruction RU e411
62/379
Roche DiagnosticsA-48 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
H:"=2^2$,=22020%"6E
Z4/@'MH#B+%F:!1#&+B1:G/3ED35+@/%3+F+&+!:?#%#%#*#G@:,R3+*/3*/
!/#
-
7/23/2019 3193 Instruction RU e411
63/379
Roche DiagnosticsA-49 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
H:"=2^2$,=22020%"6E
`/G%C$/23G/+%%'
>4BE:45N+%63?#3/63:?, *#4+E!#3:!D@4B!/#+5
7&"2'
-
7/23/2019 3193 Instruction RU e411
64/379
Roche DiagnosticsA-50 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
H:"=2^2$,=22020%"6E
=/+%Q$3J+3Y-$%(%'$/23G/+%%'
\#G@D,%#E:!*#4+E!#3:!:?=:63#?4B/36B6N3!+K-*:@*#!3:A*:,. b3#*#!3:A*#?
F:!1#3/PDF417 +@:4G%#+6=:45):?#356B66::3?/363?'MH+1+*#4+E!#3:!#1+.
2%F:!1#&+B, )#*:@+!:?#%%#B?*#!3:A*#KN3!+K-*:@:?*#4+E!#3:!:?(6=+6:*
6:@/!G+3%/?6M?:)1:G%'M+%F:!1#&+M): -:1/!3/63#
-:1/!6/!++*#4+E!#3:!#
Z/!+,%D,%:1/!*N3!+K-*:@R3+*/3*#1*#4+E!#3:!:?
\#*+/*#4+E!#3:!D@:4G%D+6=:45):?#356B+*:4+A/63?::=!/@/4/%+,@4B%+K.
r/4/?D/+4+%#)%#A/%%D/)%#A/%+B
Z!:*
-
7/23/2019 3193 Instruction RU e411
65/379
Roche DiagnosticsA-51 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
H:"=2^2$,=22020%"6E
`/G%C$%1+%2-;
>4BE:45N+%63?#3/63:?, *:%3!:4+@4B!/#
-
7/23/2019 3193 Instruction RU e411
66/379
Roche DiagnosticsA-52 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 2DG4%)3)+-:C
H:"=2^2$,=22020%"6E
e+3Y-$%($/+%Q$3$%1+%2-;
\#G@D,%#E:!*:%3!:4/,=:63#?4B/36B6N3!+K-*:@*#!3:A*#1+. b3+*#!3:A*+
3#*G/=!/@63#?4/%D?F:!1#3/PDF417 +@:4G%D+6=:45):?#356B6
6::3?/363?'MH+1+*:%3!:4B1+. -+G/=!/@63#?4/%#A#635(3./. 1:G/3ED35
E:45N/) +%F:!1#&++, *:@+!'MH/,6B?N3!+K-*:@*#!3:A*#K: -:1/!3/63#
-:1/!6/!++*:%3!:4B
\:@*:%3!:4B(%#=!+1/!, PC U1)
2@/%3+F+*#3:!6/!++@4BN3!+K-*:@R3+*/3:*.
r/4/?D/+4+%#)%#A/%%D/)%#A/%+B
\:%3!:45%D/@+#=#):%D
>#3#+63/A/%+B6!:*#
-
7/23/2019 3193 Instruction RU e411
67/379
Roche DiagnosticsA-53 5"$%'%()+'%%,-/+%/ T-)381.0
2DG4%)3)+-:C cobas e 411 /1/234/+%
H:"=2^2$,=22020%"6E
-
7/23/2019 3193 Instruction RU e411
68/379
Roche DiagnosticsA-54 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 3H%("27",/'2-138
H%("27",/'2-138
b3#
a+64:?#B*4#?+#3'!# .................................................................................. 56
8:4%#B*4#?+#3'!# ...................................................................................... 57
8!:)!#A%:635*4#?+#3'!D .............................................. ......................... 57
o!#%+4+H/@#%%DK ......................................................................................... 58
T%/N%+,=!+%3/! ............................................................................................ 58
Z/!?+6%D,+%3/!F/,6 ...................................................................................... 59
j=!#?4BMH+,+%3/!F/,6................................................................................ 59
I6%:?D=!:
Z3#3'6%#B63!:*# .............................................................................................. 61
8:@6*#)*# ......................................................................................................... 61
b*!#%D
-
7/23/2019 3193 Instruction RU e411
69/379
Roche DiagnosticsA-55 5"$%'%()+'%%,-/+%/ T-)381.0
)obas e 411 /1/234/+% 3 H%("27",/'2-138
j!:?%+@:63'=#*R*!#%#1 ................................................................................. 66
Z+63/1#2%3/!#*3+?%:,8:1:H+.......... ............................................. ........ 67
-
7/23/2019 3193 Instruction RU e411
70/379
Roche DiagnosticsA-56 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 3H%("27",/'2-138
L)6:)+"+%E
=%:,%1-1+C
]:@'45'=!#?4/%+B6:63:+3+)64/@'MH+K*:1=:%/%3:
r?/3%:,1:%+3:!66/%6:!%D1R*!#%:1
\4#?+#3'!#
o!#%+4+H/@#%%DK
T%/N%+,=!+%3/!
Z/!?+6%D,+%3/!F/,6
j=!#?4BMH+,+%3/!F/,6
H%13+%))-1)%1C:V$/1%:
39 61(15@) &?/3%:,1:%+3:!66/%6:!%D1R*!#%:1!#6=:4:G/%?4/?:,?/!K%/,
A#63+#%#4+)#3:!#++6=:45)'/36B@4B:
I3:E!#G/%+B+%F:!1#&++ -#?+
+6=:45):?#%++ 6/%6:!%:
6=+6:*, 3/*63:?:/=:4/+4+*%:=*') @4B?D=:4%/%+B?#N/,)#@#A+. -#=!+1/!,
@4B:3:E!#G/%+BR*!#%#IE):!>#%%DK?1/%MP#E:A//]/63:, ?DE/!+3/
P#E:A//]/63:, #)#3/1?DE/!+3/)#*4#@*'IE):!>#%%DK.
-
7/23/2019 3193 Instruction RU e411
71/379
Roche DiagnosticsA-57 5"$%'%()+'%%,-/+%/ T-)381.0
3 H%("27",/'2-138 cobas e 411 /1/234/+%
L)6:)+"+%E
53). A-22 ]+-$':-?B/2:"-
K%L/::1/8$2/'3/+"/
8!:
F3)2%'/8$2/'3/+"/
A Q-'&2":+*.5"
&')-'B
2)"
-
7/23/2019 3193 Instruction RU e411
72/379
Roche DiagnosticsA-58 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 3H%("27",/'2-138
L)6:)+"+%E
K%21/8$2/'3/+"/
A Q-'&2"&:'4:"E-'$1. B Q-'&2":+*.5"E.$)'
=:4%:,*4#?+#3'!:,+A+64:?:,*4#?+#3'!:,.
K%4/Q1%)+7$2/'3/+"C
TD1:G/3/'=!#?4B35=!:)!#A%:635M=!:
*4#?+#3'!:,, E/)%/:EK:@+1:63+:3:@?+
-
7/23/2019 3193 Instruction RU e411
73/379
Roche DiagnosticsA-59 5"$%'%()+'%%,-/+%/ T-)381.0
3 H%("27",/'2-138 cobas e 411 /1/234/+%
L)6:)+"+%E
g/1-13-(/11CY
Z+63/1#+6=:45)'/3F4RN-=#1B35, *#!3:A*+=#1B3+, +CD-ROM @4BK!#%/%+B
@#%%DK. +)+A/6*:
>#%%D/4::20000 @%/?%DKE4:*:?6+:1000 4::180 4:
8!+6:/@+%+3/=!+%3/!*USB =:!3', 1#!*+!:?#%%:1'PRINTER %#4/?:,63:!:%/
#%#4+)#3:!#. Z1. %#64/@'MH/1!+6'%*/!#6=:4:G/%+/@#%%:
-
7/23/2019 3193 Instruction RU e411
74/379
Roche DiagnosticsA-60 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 3H%("27",/'2-138
L)6:)+"+%E
53). A-25 "$&')'*+-.+&':1'@-'3)1C;31+->-;)
Z/!?+6%D,=:!3+6=:45)'/36B@4B=!+6:/@+%/%+B?%/N%/-;)
2%63!'1/%31:G/3ED356?B)#%6'=!#?4BMH/,6+63/1:,=:@?'%#=!#?4/%%:1'
+%3/!F/,6'.
Z?BG+3/656_/K%+A/6*:,8:@@/!G*:,Roche @4B=:4'A/%+B+%F:!1#&++
+4+=:1:H+=:+6=:45):?#%+M#%#4+)#3:!#cobas e 411 6'=!#?4BMH/,
6+63/1:,.
-
7/23/2019 3193 Instruction RU e411
75/379
Roche DiagnosticsA-61 5"$%'%()+'%%,-/+%/ T-)381.0
3 H%("27",/'2-138 cobas e 411 /1/234/+%
\0+)/E:')D',66+)D))X"0:"9"+2.
D)1%'C,%L/::1%L%%G-),-Q-138
b3# 6/*&+B 6:@/!G+3 :E):! 6+63/1%::=+6#%+/164/@'MH+KR*!#%%DKR4/1/%3:?:
Z3#3'6%#B63!:*#
8:@6*#)*#
b*!#%D4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++61. 6/*&+M8!:
2%3/!#*3+?%:,8:1:H+.
H$'2+_)%E, 0)
-
7/23/2019 3193 Instruction RU e411
76/379
Roche DiagnosticsA-62 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 3H%("27",/'2-138
\0+)/E:')D',66+)D))X"0:"9"+2.
@+/+")1/8)+%$/
Z3#3'6%#B63!:*#:3:E!#G#/36B%#?/!K'*#G@:?:,%#B+*:%*#63#3'6#64/?#+)1/%B/3&?/3@4B:3!#G/%+B3/*'H/
-
7/23/2019 3193 Instruction RU e411
77/379
Roche DiagnosticsA-63 5"$%'%()+'%%,-/+%/ T-)381.0
3 H%("27",/'2-138 cobas e 411 /1/234/+%
\0+)/E:')D',66+)D))X"0:"9"+2.
_$/1CL2/'1%L%:-1P
h!#F+A/6*+,=:45):?#3/456*+, +%3/!F/,6, +6=:45)'/1D,?1:@'4/'=!#?4/%+B,
6:63:+3+)N/63+:6%:?%DKR*!#%:?:
IE):!6+63/1D(System Overview)
P#E:A//1/63: (Workplace)
P/#4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.Q)!?7)/,%"!?0$2"J')/+2
DG4%)3)+-:C(System Overview)
b*!#%Z+63/1%D,IE):!(System Overview) B?4B/36B&/%3!#45%D1R*!#%:1@4B
?D=:4%/%+B=:?6/@%/?%DK:=/!#&+,. I36M@#?D1:G/3/=!:61#3!+?#3563#3'6
!/#5/G%Q--:-)+%(Workplace)
b*!#%P#E:A//]/63:(Workplace) 6:63:+3+)@?'K:6%:?%DK)#*4#@:*: TDE:!_/63:?
(Test Selection) +IE):!>#%%DK(Data Review).
TDE:!_/63:?(Test Selection) +6=:45)'/36B@4B??:@#+=!:61:3!#?DE:!*+3/63:?
@4B:E!#).
IE):!>#%%DK(Data Review) +6=:45)'/36B@4B=:+6*#, :E):!#,!/)/!?+!:?#%+B,
'@#4/%+B+=:6D4*+@#%%DK*'=!#?4BMH/,6+63/1/.
e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.%"'(*++-+./(Workplace menu) ?
6/*&++:=+6#%+B=!:
5-/L-1+C(Reagent)
b*!#%]/%MP/#
-
7/23/2019 3193 Instruction RU e411
78/379
Roche DiagnosticsA-64 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 3H%("27",/'2-138
=/23G%'$/(Calibration)
QC
]+323+/(Utility)
O/$2/($3H-1P
K%28),3)$%'
\0+)/E:')D',66+)D))X"0:"9"+2.
b*!#%1/%M\#4+E!:?*#(Calibration) 6:63:+3+)3!/K)#*4#@:*: Z3#3'6(Status,
\#4+E!#3:!D(Calibrator) +j63#%:?*#(Install). I%++6=:45)'M36B @4B)#=!:6#
*#4+E!:?:*, '63#%:?*+*#4+E!#3:!:? , +=!:61:3!#!/)'453#3:?*#4+E!:?:*.
e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.`"+PL,!2X')/$,(Calibration
menu) ?6/*&++:=+6#%+B8!:
b*!#%1/%MQC 6:63:+3+)N/63+)#*4#@:*: Z3#3'6(Status), Z3#3'6TD=:4%/%+B
(Run Status), 2%@+?+@'#45%D/(Individual), \'1'4B3+?%D/(Cumulative),
\:%3!:45(Control) +j63#%:?*#(Install). 26=:45)',3/R3+R*!#%D@4B'63#%:?*+,
=!:61:3!#+!/@#*3+!:?#%+B*:%3!:4/,, :&/%*++#**'1'4+!:?#%+B!/)'453#3:?
*:%3!:4B*#A/63?#
e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.`"+PQC (QC menu) ?6/*&++
:=+6#%+B8!:
b*!#%1/%Mj3+4+3#(Utility) 6:63:+3+)A/3D!/K)#*4#@:*: Z+63/1#(System),
IE64'G+?#%+/(Maintenance), 8!+4:G/%+/(Application) +TDA+64B/1D,_/63
(Calculated Test). b3+R*!#%D+6=:45)'M36B@4B??:@#6+63/1%DK%#63!:/*,
=#!#1/3!:?=!+4:G/%+,+@:63'=#*F'%*&+B1:E64'G+?#%+B+6/!?+6#.
e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++, 61.`"+PS%2!2%,(Utility Menu)
?6/*&++:=+6#%+B8!:
TD1:G/3/+6=:45):?#35)#*4#@*+1/%M, @4B?DE:!#R*!#%:?+:*:%
6
e#*4#@*+1/%M=B35: P#E:A//]/63:(Workplace), P/#
:=!/@/4/%%:1%#=!#?4/%++. _/*'H+,?DE:!'*#)D?#/36B*'!6:!:1?DE:!#
=:@6?/3*:,. TD1:G/3/3#*G/+6=:45):?#35*4#?+N+Home, End, Page Up, +Page
Down %#=:4%:,=!:
3!/E'/1D,R4/1/%3E'@/3?D@/4/%, %#G1+3/Enter (??:@).
-
7/23/2019 3193 Instruction RU e411
79/379
Roche DiagnosticsA-65 5"$%'%()+'%%,-/+%/ T-)381.0
3 H%("27",/'2-138 cobas e 411 /1/234/+%
\0+)/E:')D',66+)D))X"0:"9"+2.
[-$)+%'C-,%28
=1%,$3%,?3;
=1%,$3
_/*63:?:/=:4/ =:)?:4B/3??:@+35+%F:!1#&+M. -/*:3:!D/3/*63:?D/=:4B
+6=:45)'M36B@4B:3:E!#G/%+B+%F:!1#&++. >!'
\:6%+3/65R3:,*%:=*+@4B)#*!D3+B:*%#.
-
7/23/2019 3193 Instruction RU e411
80/379
Roche DiagnosticsA-66 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 3H%("27",/'2-138
H)Y',+2%?(Save)
\X+)/2%?(Update)
H%',+29+E"$+):$2
(Page Buttons)
\0+)/E:')D',66+)D))X"0:"9"+2.
\:6%+3/65R3:,*%:=*+@4B6:K!#%/%+B4MEDK+)1/%/%+,, 6@/4#%%DK?3/*'H/1
:3:E!#G#/1:1R*!#%//:*%/. 8:64/?D=:4%/%+B+)1/%/%+,, *%:=*#63#%:?+36BG/43:,.
\:6%+3/65R3:,*%:=*+@4B:E%:?4/%+B@#%%DK, *:3:!DK*#6#M36B
=!:+)?:@+1D/?3/*'H/1R*!#%//:*%/+)1/%/%+B. 8:64/?D=:4%/%+B
+)1/%/%+,, *%:=*#63#%:?+36BG/43:,.
-/*:3:!D/R*!#%D+1/M363!#%+A%D/*%:=*+, *:3:!D/1:
-
7/23/2019 3193 Instruction RU e411
81/379
Roche DiagnosticsA-67 5"$%'%()+'%%,-/+%/ T-)381.0
3 H%("27",/'2-138 cobas e 411 /1/234/+%
\0+)/E:')D',66+)D))X"0:"9"+2.
D$1/
\$+,
:)+#=#):%#IE!#)&:?(Sample Range Start). -#)?#%+/*%:=*+
+)1/%+356B %# \:%/& >+#=#):%# IE!#)&:? (Sample Range End) + &?/3 //
+)1/%+356B%#E/4D,.
3 TDE/!+3/=:64/@%+,:E!#)/&6=+6*#+)6=+6*#64/?#R*!#%#. 26=:45)',3/
=:4:6D=!:*!'3*+@4B:3:E!#G/%+B:E!#)&:?, *:3:!D/%#K:@B36B?%+)' 6=+6*#.
4 \:6%+3/65\:%/&>+#=#):%#IE!#)&:?(Sample Range End). TDE!#%%D/
:E!#)&D=:@6?/3B36B6+%+1F:%:1.
]%'13(%)+",/$V$/1/:
>:63'= * %/*:3:!D1 R*!#%#1, :6:E/%%: * 3/1, *:3:!D/ %#K:@B36B ? 1/%M j3+4+3#
(Utility), :
'!:?%B @:63'=# :=/!#3:!#, 4+E: %/ 1:
-
7/23/2019 3193 Instruction RU e411
82/379
Roche DiagnosticsA-68 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 3H%("27",/'2-138
\0+)/E:')D',66+)D))X"0:"9"+2.
@3)+-:/91+-/$+3'1%;,%:%M3
cobas e 411 +1//3*:%3/*63%:-A'?63?+3/45%'M+%3/!#*3+?%'M=:1:H5, *:3:!#B
1:G/364'G+35=:1:H%+*:1=!+R*6=4'#3#&++6+63/1D. \:%3/*63%:-
A'?63?+3/45%#B :)%#A#/3, A3:=!+4:G/%++cobas e 411, ?DE:!F'%*&+M=:1:H+:3:E!#G#/3?6=:1:
-
7/23/2019 3193 Instruction RU e411
83/379
Roche DiagnosticsA-69 5"$%'%()+'%%,-/+%/ T-)381.0
3 H%("27",/'2-138 cobas e 411 /1/234/+%
\0+)/E:')D',66+)D))X"0:"9"+2.
-
7/23/2019 3193 Instruction RU e411
84/379
Roche DiagnosticsA-70 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
=%:,%1-1+C/1/234/+%/
b3#
-
7/23/2019 3193 Instruction RU e411
85/379
Roche DiagnosticsA-71 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
\:1=:%/%3D+)1/!+3/45%:,:E4#63+ .................................................................. 97
2%*'E#3:!.......................................................................................................... 97
Z+==/!%D,):%@+=!:1D?:A%#B63#%&+B ..................................................... 98
Z+==/!%D,=+=/33/! .............................. ............................................. ........ 99
Z+63/1%D/!/#
-
7/23/2019 3193 Instruction RU e411
86/379
Roche DiagnosticsA-72 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
\X7)'$)6:)+"+%,+,!27,%)',
DG4%$%:,%1-1+/1/234/+%/
\:1=:%/%3D#%#4+)#3:!#cobas e 411,!#)1/H#MH+/6B?!#)4+A%DK:E4#63BK:
IE4#635IE!#)&:?/P/#+6*IE!#)&:?
d3#3+?%D,E4:*
e:%@(S/R) :E!#)&:?/!/#
-
7/23/2019 3193 Instruction RU e411
87/379
Roche DiagnosticsA-73 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
=%:,%1-1+C%G2/)+3%G/4?%'/-/L-1+%'
IE4#635:E!#)&:?/!/#
-
7/23/2019 3193 Instruction RU e411
88/379
Roche DiagnosticsA-74 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
^3)$%G/4?%'
>+6*:E!#)&:?+1//330 =:)+&+,@4B:E!#)&:?, *#4+E!#3:!:?+*:%3!:4/,. TD
1:G/3/=:1/H#35:E!#)&D=#&+/%3:?4+E:?=/!?+A%D/=!:E+!*+:E!#)&:?,
4+E:?=!:E+!*+:E!#)&:?. T63!:/%%D/#@#=3/!D=:)?:4BM361/N+?#35
=/!?+A%D/=!:E+!*+!#)4+A%DK!#)1/!:?.
e >/3#4+=:+6=:45):?#%+M=/!?+A%DK=!:E+!:*61. ?!#)@/4/H20%"6,\X',7=)/
%#63!. A-40.
TD1:G/3/=:1/H#35=!:E+!*+:E!#)&:?[3:45*:2 14(Z3#%@#!3%D/)
Hitachi =!:E+!*+] =!B1:%#@+6*:E!#)&:?, 4+E:%#?/!N+%'16 11
=/!?+A%DK=!:E+!:*.
c!.:)!J9"+2.)X["T2+ )'6,=22:)X"7):,0+)0%2,06.
>0:)!?7)/,+2"62$')-9,_"$+,0%'. A-17.
53). A-31 c.$2'3:"4I'
-
7/23/2019 3193 Instruction RU e411
89/379
Roche DiagnosticsA-75 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
e+/+3'1C;G2%$
d3#3+?%D,E4:*6:63:+3+)A-4+%++, B-4+%++, C-4+%+++STAT
(\:!:3*:-
TK:@%:,E'F/!, =:*#)#%%D,%#64/@'MH/1!+6'%*/, +1//31/63:@4B=B3+
@:=:4%+3/45%DKN3#3+?:?. 8:R3:1', @:E#?+?+K*15 N3#3+?#1%#A-4+%++, ?D
=:4'A+3/?6/
-
7/23/2019 3193 Instruction RU e411
90/379
Roche DiagnosticsA-76 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
53). A-33
B-23138
R@'6-'B37Y+:>1"1.
-
7/23/2019 3193 Instruction RU e411
91/379
Roche DiagnosticsA-77 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
TCY%(1%;G">-
d3#3+?D6
53). A-35 R?@'6-'B37Y+:$>1"1.
-
7/23/2019 3193 Instruction RU e411
92/379
Roche DiagnosticsA-78 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
C-23138
\:1"1.
-
7/23/2019 3193 Instruction RU e411
93/379
Roche DiagnosticsA-79 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
STATJ+/+3'1/8,%43?38
STAT (\:!:3*:1"1.
-
7/23/2019 3193 Instruction RU e411
94/379
Roche DiagnosticsA-80 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
e+/+3'C
8!:E+!*+:E!#)&:?, =/!?+A%D/=!:E+!*+:E!#)&:?, /1*:63+*#4+E!#3:!:?+4+
*:%3!:4/,=:1/H#M36B?N3#3+?D, *#*=:*#)#%: %+G/. \#G@D,N3#3+?1:G/3
6:@/!G#351#*6+1'1=B35:E!#)&:?. \#G@D,64:3@4B=!:E+!*++1//3
#@#=3/!D, *:3:!D/=:)?:4BM3=:1/H#35?N3#3+?=/!?+A%D/=!:E+!*+
:E!#)&:?!#)4+A%DK!#)1/!:?. \#G@D,N3#3+?+1//3'%+*#45%D,ID,)#*:@+!:?#%%D,?N3!+K-*:@R3+*/3*/%#)#@%/,A#63+N3#3+?#. b3:3ID
N3#3+?#6A+3D?#/36B6*#%/!:1+=/!/@#/36B?6+63/1'. I%)#3/1:3:E!#G#/36B
*#*%#R*!#%#K3#*+?:3A/3#K.
A M1:.@-2'6ID>1"1.
-
7/23/2019 3193 Instruction RU e411
95/379
Roche DiagnosticsA-81 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
O%1((S/R) %G/4?%'/-/L-1+%'
e:%@:E!#)&:?/!/#:=:4%+3/45%D/%#*:%/A%+*++6=:45)'M36B@4B
!#)E#?4/%+B:E!#)&:?+=!/@?#!+3/45%:,=:@
'",D"+%)/%#63!. A-46.
Z*#%/!N3!+K-*:@:?#?3:-@+FF/!/&+!'MH+,, A3:=:)?:4B/3+6=:45):?#35
!#)4+A%D/3+=DN3!+K-*:@:??:?!/1B!#E:3D. Z*#%/!3#*G/6=:6:E/%
6A+3D?#35N3!+K-*:@DF:!1#3#PDF417.
-
7/23/2019 3193 Instruction RU e411
96/379
Roche DiagnosticsA-82 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
e >4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++61. L)+=":=2.F",D"+%)/(Reagent concept) ?COBI-CD.
TD 1:G/3/ '?+@/35 6*#%/! N3!+K-*:@:? %# N3#3+?%:, 6+63/1/, /64+ '@#4/%
!/#4B 6A+3D?#%+B N3!+K-*:@ R3+*/3:*, 6*#%/! ?!#H#/36B 1/G@'
!/#4B=:4'A/%+B+%F:!1#&++:?3:!:16*#%/!/N3!+K-*:@:?, 61. H$,+"'_%'2Y-
$)1:.@-2'62"1:'E2.2").3:"1':".).2'-1:')= B ])'1$2"-+:">1:.@-2'6'
-
7/23/2019 3193 Instruction RU e411
97/379
Roche DiagnosticsA-83 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
A ])'1$2"-+:">1:.@-2'6'
-
7/23/2019 3193 Instruction RU e411
98/379
Roche DiagnosticsA-84 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
@$/1-J+3Y-$%(%'J+/+3'%'3)-1)%%G/4?%'
Z*#%/!N3!+K-*:@:?N3#3+?:?, 6A+3D?#/3*#*N3!+K-*:@R3+*/3*+:E!#)&:?, 3#*
+N3#3+?:?. Z*#%/!#?3:-@+FF/!/%&+!'MH+,, A3:=:)?:4B/3+6=:45):?#35
!#)4+A%D/3+=DN3!+K-*:@:??:?!/1B!#E:3D. -#E:!D6+1?:4:?N3!+K-*:@:?
1::=:4%+3/45%:*6*#%/!' N3!+K-*:@:?, +1//36B3#*G/ 6/%6:!:E!#)&:?,
*:3:!D,:=!/@/4B/3, +1//36B4+=!:E+!*#?=:)+&++N3#3+?#.
A ])'1$2"-+:">1:.@-2'6'
-
7/23/2019 3193 Instruction RU e411
99/379
Roche DiagnosticsA-85 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
@+/1?38)Q3+C'/138J+3Y-$%($/+%Q-$
-#R3:,63#%&++, 6*#%/!N3!+K-*:@:?6A+3D?#/3+%F:!1#&+M=:
*#4+E!#3:!#1+*:%3!:4B16+KN3!+K-*:@*#!3:A/*. b3+*#!3:A*+
=:63#?4BM36B6%#E:!#1+*#4+E!#3:!:?+*:%3!:4/,. \:4B=:4'A/%+B@:=:4%+3/45%:, +%F:!1#&++:
M%'2Y-$)
-
7/23/2019 3193 Instruction RU e411
100/379
Roche DiagnosticsA-86 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
5-/L-1+1C;%+%
P/#1#*6+1#45%:/*:4+A/63?:!/#
-
7/23/2019 3193 Instruction RU e411
101/379
Roche DiagnosticsA-87 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
H-Y/134:%+$C+38/4/$C+38$CJ-$-/L-1+%'
>4B=!/@:3?!#H/%+B+6=#!/%+B!/#+2:+"D+-1'
-
7/23/2019 3193 Instruction RU e411
102/379
Roche DiagnosticsA-88 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
53). A-47 K.2:'>":.2'
-
7/23/2019 3193 Instruction RU e411
103/379
Roche DiagnosticsA-89 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2)X',7=)//'",D"+%)/
K3,-++-%G/4?%'/-/L-1+%'(S/R)
S/R =+=/33/!!#6=:4:G/%6=!#?#%#)#@%/,A#63+#%#4+)#3:!#. 8+=/33/!)#=:4%/%
6+63/1%:,?:@:,++6=:45)'/3=:4:G+3/45%:/)#1/H/%+/@4B)#E:!#+
?D6?:E:G@/%+B+)S/R ):%@#
A V.&+11+:'3:"4I'
-
7/23/2019 3193 Instruction RU e411
104/379
Roche DiagnosticsA-90 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2',0Y)
-
7/23/2019 3193 Instruction RU e411
105/379
Roche DiagnosticsA-91 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2',0Y)
-
7/23/2019 3193 Instruction RU e411
106/379
Roche DiagnosticsA-92 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2',0Y)
-
7/23/2019 3193 Instruction RU e411
107/379
Roche DiagnosticsA-93 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2',0Y)
:)72=2)+2')/,++ET$)+%"T+"', /E7E/,"%:"'"Y)
-
7/23/2019 3193 Instruction RU e411
108/379
Roche DiagnosticsA-94 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2',0Y)
-
7/23/2019 3193 Instruction RU e411
109/379
Roche DiagnosticsA-95 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2',0Y)
-
7/23/2019 3193 Instruction RU e411
110/379
Roche DiagnosticsA-96 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E)X!,0%2',0Y)
-
7/23/2019 3193 Instruction RU e411
111/379
Roche DiagnosticsA-97 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E)X!,0%2',0Y)
-
7/23/2019 3193 Instruction RU e411
112/379
Roche DiagnosticsA-98 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E276"'2%"!?+)T7)+E
=%:,%1-1+C34:-3+-271%;4%1C
2)1/!+3/45%#B):%#6:@/!G+364/@'MH+/*:1=:%/%3D:
2%*'E#3:!
Z+==/!%D,):%@+=!:1D?:A%#B63#%&+B
Z+==/!%D,=+=/33/!
Z+63/1%D/!/#
-
7/23/2019 3193 Instruction RU e411
113/379
Roche DiagnosticsA-99 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E276"'2%"!?+)T7)+E
@3,,-1C;4%1(3,%:C'%Q1/8)+/1?38
Z+==/!%D,):%@)#E+!#/3!/#*&+:%%'M61/65?+)1/!+3/45%'M BA/,*', #
3#*G/?DE+!#/3ProCell +CleanCell. P#6=:4#
-
7/23/2019 3193 Instruction RU e411
114/379
Roche DiagnosticsA-100 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E276"'2%"!?+)T7)+E
K3,-++-)3,,-/
8+=/33/!6+==/!#!#6=:4:G/%6=!#?#:3=+=/33/!#:E!#)&:?/!/#
-
7/23/2019 3193 Instruction RU e411
115/379
Roche DiagnosticsA-101 5"$%'%()+'%%,-/+%/ T-)381.0
4 =%:,%1-1+C/1/234/+%/ cobas e 411 /1/234/+%
L)6:)+"+%E276"'2%"!?+)T7)+E
@3)+-:1C--/L-1+C(ProCell 3CleanCell)
ProCell +CleanCell 6:@/!G#36B?E'3D4*#K?:E4#63+=+=/33!#, )#*:%3/,%/!:1
@4BG+@*+K:3K:@:?.
ProCell R3:E'F/!%D,!#63?:!, 6:@/!G#H+,3!+!:=+4#1+%(TPA). C'3D4*+
ProCell +@/%3+F+&+!'M36B=:E/4D1*!DN*#1.
CleanCell R3::A+H#MH+,!#63?:!, +6=:45)'/1D,@4B:A+63*+
+)1/!+3/45%:,BA/,*+=:64/+)1/!/%+B. C'3D4*+CleanCell
+@/%3+F+&+!'M36B=:A/!%D1*!DN*#1.
>?/E'3D4*+*#G@:
-
7/23/2019 3193 Instruction RU e411
116/379
Roche DiagnosticsA-102 5"$%'%()+'%%,-/+%/ T-)381.0
cobas e 411 /1/234/+% 4 =%:,%1-1+C/1/234/+%/
L)6:)+"+%E276"'2%"!?+)T7)+E
A f"T+)2"T.12"$.&&+:" B _"3':371?)'22
C _"3':371?)'21 D g.1'2$.&&+:"(
-
7/23/2019 3193 Instruction RU e411
117/379
_$),2"/+/?38
5 \X7)'..................................................................................... B-3
6 Q)/0"
-
7/23/2019 3193 Instruction RU e411
118/379
-
7/23/2019 3193 Instruction RU e411
119/379
Roche DiagnosticsB-3 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 5DG4%
DG4%
b3#
P'*:?:@63?:=:R*6=4'#3#&++ ................................................................................ 5
>+6*:?D/+N3#3+?%D/6+63/1D............................................................................. 5
8!:
-
7/23/2019 3193 Instruction RU e411
120/379
Roche DiagnosticsB-4 5"$%'%()+'%%,-/+%/ T-)381.0
)obas e 411 /1/234/+% 5 DG4%
-
7/23/2019 3193 Instruction RU e411
121/379
Roche DiagnosticsB-5 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 5DG4%
FJ$)/)T!'*:?:@63?/=:R*6=4'#3#&++?D%#,@/3/:
8!:&/@'!D/G/@%/?%:,R*6=4'#3#&++
8!:&/@'!D/G/@%/?%:
K%L/::1/8$2/'3/+"/
8!:
6/%6:!%:1 R*!#%/, =: 1/!/ %/:EK:@+1:63+. T )#?+6+1:63+ :3 3+=#
??:@+1DK @#%%DK, 1:G/3 :3:E!#G#356B 4+E: A+64:?#B *4#?+#3'!#, 4+E:
=:4%#B.
-#!+6'%*#K%+G/=!/@63#?4/%D:E#?+@#=!:
-
7/23/2019 3193 Instruction RU e411
122/379
Roche DiagnosticsB-6 5"$%'%()+'%%,-/+%/ T-)381.0
5DG4% cobas e 411 /1/234/+%
Q')D',66+,.$!,/2,%J',
53). B-2 V')-"=(372
-
7/23/2019 3193 Instruction RU e411
123/379
Roche DiagnosticsB-7 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
K%')-(1-'1/8V$),2"/+/?38
TR3:,Z=+6:*)#
-
7/23/2019 3193 Instruction RU e411
124/379
Roche DiagnosticsB-8 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Z*#%+!:?#%+/N3!+K-*:@*#!3:A/**#4+E!#3:!:?+*:%3!:4/,............ 33
e#
V*3+?#&+BQC 3/63# .................................................................................... 36
2)1/!/%+/*#4+E!#3:!:?+*:%3!:4/, ..................................................... 36
8:@3?/!G@/%+/!/)'453#3:?*#4+E!:?*++*:%3!:4/,.................................. 38
V**'1'4+!:?#%+/!/)'453#3:? QC ............................................................ 41\:!!/*3%#B'63#%:?*#13 11=!:E+!:*:E!#)&:?%#@+6*:E!#)&:? ............ 41
\:!!/*3%#B'63#%:?*#13 11=!:E+!:*:E!#)&:?%#N3#3+? ......................... 43
2)1/!/%+B63#%@#!3%DK:E!#)&:?: @+6*:?#B6+63/1# .................................... 45
8!:
+%3/!F/,6:1. ......................................................................................... 45
8!:
+%3/!F/,6:1 ................................................................................................ 47
8!:
+%3/!F/,6#................................................................................................... 48
8!:
+%3/!F/,6# .................................................................................................. 50
2)1/!/%+B63#%@#!3%DK:E!#)&:?: N3#3+?%#B6+63/1# .................................. 538!:
+%3/!F/,6:1 ............................................................................................... 53
8!:
+%3/!F/,6:1 ................................................................................................ 54
8!:
+%3/!F/,6#................................................................................................... 56
8!:
+%3/!F/,6#................................................................................................... 58
2)1/!/%+/@:=:4%+3/45%DK63#%@#!3%DK:E!#)&:? ......................... ......... 60
-/=!/!D?%#B)#
................................................................................................................ 62-/=!/!D?%#B)#
V?3:1#3+A/6*:/ !#)E#?4/%+/#%#4+)#3:!:1 ............................................ 75
I364/G+?#%+/:E!#)&:?: @+6*:?#B6+63/1# .................................................... 76
I364/G+?#%+/:E!#)&:?: N3#3+?%#B6+63/1# ................................................. 77
e#
-
7/23/2019 3193 Instruction RU e411
125/379
Roche DiagnosticsB-9 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
P/)'453#3D .......... ............. ............. ............ ............. ........... ............. ............ .......... .... 81
8!:61:3!!/)'453#3:?=:=#&+/%3#1 .............................................................. 82
+453!#&+B!/)'453#3:?=:=#&+/%3#1 .......................................................... 84
P#6=/A#3*#+4+)#
I=&++:E4#63+TD=:4%/%+Bj64:?+,(Completion Conditions).............. 85
I=&++:E4#63+8!+6:/@+%/%+/8!+%3/!:?(Printer Connection) . ......... 85
I=&++:E4#63+V?3:1#3+A/6*#BP#6=/A#3*#(Automatic Printout) ......... 85
P#6=/A#3*#I3A/3#=:P/)'453#3#1(Result Report) ................. ............ ........ 85
j=!#?4/%+/=:63-:=/!#&+:%%D1+@#%%D1+ ....................................................... 87
IE):!!/)'453#3:? .................................... ............................................. ........ 87
j@#4/%+/@:*'1/%3+!:?#%%DK:E!#)&:?. ...... 87
>%/?%:/:E64'G+?#%+/ .......................................................................................... 87
TD*4MA/%+/#%#4+)#3:!# ...................................................................................... 88
8!/@:3?!#H/%+/+6=#!/%+B6+63/1%DK!/#
-
7/23/2019 3193 Instruction RU e411
126/379
-
7/23/2019 3193 Instruction RU e411
127/379
Roche DiagnosticsB-11 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
\X7)'
DG4%
8:?6/@%/?%#B!#E:3#?*4MA#/363#%@#!3%D/)#@#A+, *:3:!D/%/:EK:@+1:
?D=:4%B35@4B=:@=!/@63#?4B/3:E):!=!:&/66:?@%/?%:,!#E:3D.
(a)Short Turn Around Time- \:!:3*:
-
7/23/2019 3193 Instruction RU e411
128/379
Roche DiagnosticsB-12 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q'"
e#1/%#%/:EK:@+1DK!/#
e#=!:6*:%3!:4/, Z=+6:*)#
2)1/!/%+/*#4+E!#3:!:?+*:%3!:4/, b*!#%j64:?+Be#='6*#(Start Conditions)
8:@3?/!G@/%+/*#4+E!:?:*+!/)'453#3:?*:%3!:4/, (-/3)
[/G23?/B- 1 ]&.$'2&:'
-
7/23/2019 3193 Instruction RU e411
129/379
Roche DiagnosticsB-13 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q'"
e#='6*:E!#E:3*+
I364/G+?#%+/:E!#E:3*+:E!#)&:?
(TD=:4%B/36B%#'=!#?4BMH/,6+63/1/)
(-/3)
b*!#%j64:?+Be#='6*#(Start Conditions)
I*%:I364/G+?#%+/IE!#)&:?
(Sample Tracking)
I&/%*#!/)'453#3:?
P#6=/A#3*#:3A/3#
8!:61:3!!/)'453#3:?
j@#4/%+/@:*'1/%3+!:?#%%DK:E!#)&:?
b*!#%IE):!>#%%DK (Data Review)
b*!#%IE):!>#%%DK (Data Review)
b*!#%IE):!>#%%DK (Data Review)
>%/?%:/:E64'G+?#%+/
IA+63*#S/R):%@#
TD=:4%/%+/:E64'G+?#%+/F+%#4+)#&++(=!+%/:EK:@+1:63+)
TD*4MA/%+/
(-/3)
I*%:+%#4+)#&+B(Finalization)
I*%:e#?/!N/%+BP#E:3D(Shutdown)
[/G23?/B- 1 ]&.$'2&:'0:)!?7JT%"W$',+S%2!2%,(Utility) >H20%"6,(Utility > System)(Utility > System)
8!+?*4MA/%++, ?D=:4%B/36B+%+&+#4+)#&+B, #)#3/16+63/1#=/!/K:@+3?!/G+1
:G+@#%+B.
-
7/23/2019 3193 Instruction RU e411
130/379
Roche DiagnosticsB-14 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q'"
-
7/23/2019 3193 Instruction RU e411
131/379
Roche DiagnosticsB-15 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q'"
-
7/23/2019 3193 Instruction RU e411
132/379
Roche DiagnosticsB-16 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q'"
-
7/23/2019 3193 Instruction RU e411
133/379
Roche DiagnosticsB-17 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
K%'-$/)3)+-:1CY)3L1/271CY)%%GM-13;
X64+ED4:
e Z1. N$!P9"+2"%J6X!"')/:2%,+2.%#63!. B-14.
-
7/23/2019 3193 Instruction RU e411
134/379
Roche DiagnosticsB-18 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q)
=!:
4ME:/?!/1B. b3:3R*!#%:3:E!#G#/363#3'6*#G@:
#%#4+)#3:!#.
9$%1$/
j=!.6+6-1#(Host)
i'-+
Z+%+,
e/4/%D,
O1/Q-13-
\:11'%+*#&+B6'=!. 6+63/1:,%#63:!:%/#%#4+)#3:!#cobase 411 ?D*4MA/%#(%/)#?+6+1::3@:63'=#*'=!#?4BMH/,6+63/1/).
\:11'%+*#&+B6'=!. 6+63/1:,%#63:!:%/#%#4+)#3:!#cobase 411 ?*4MA/%#(%/)#?+6+1::3@:63'=#*'=!#?4BMH/,6+63/1/).
-
7/23/2019 3193 Instruction RU e411
135/379
Roche DiagnosticsB-19 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q)
-
7/23/2019 3193 Instruction RU e411
136/379
Roche DiagnosticsB-20 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q)
R$+3'1%-(Active)
K-(",-B(-13-(Warning)
K-(%)+--B-13-(Caution)5-B3:%B3(/138(Standbye)
`%27+-)+%',9),%274%'/1
@'%G%(1/8,%4.
K%)%Q-1.
^-;)+'3+-271/
O/,%J-1/
`-"(/2/)7
^-;)+'3+-2-1
O/,%J-1
`/"J-13-
K%)+%Q-1.
P/# System)(Z3!. 2/3) >
8!:?/!*#j!:?%BP/#4B@#%%:A+64:1% %+G/. \:4:%*#PC1 =!/@63#?4B/3E'3D4*'1 +PC2 E'3D4*'2.
h:4'E#B=#%/45'*#)D?#/3*:4+A/63?::63#MH/
-
7/23/2019 3193 Instruction RU e411
137/379
Roche DiagnosticsB-21 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q)
-
7/23/2019 3193 Instruction RU e411
138/379
Roche DiagnosticsB-22 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q)
(Reagent Load List), Z=+6:*e#
8#!#1/3!:?(Parameter Download), +I364/G+?#%+/IE!#)&:?(Sample Tracking).
r?/3*#G@:,*%:=*+?#!5+!'/36B, ?)#?+6+1:63+:363#3'6#, TDE:!R3+K
*%:=:*:3:E!#G#/3R*!#%D+:*%#, *:3:!D/=:)?:4BM3=:45):?#3/4B1
=!/@=!+%+1#35@/,63?+B%/:EK:@+1D/@4B*#G@:,*:%*!/3%:,6+3'#&++.
26=:45)',3/IE64'G+?#%+/(Maintenance) %#R*!#%/Z+63/1%:#%%DK=::E!#)(Sample Data Clear) , *:#%%DK=::E!#)(Sample Data Clear) @4B'@#4/%+B!/)'453#3:?=
:E!#). IA+63*#>#%%DK=::E!#)(Sample Data Clear) '@#4B/3?6/)#=+6+=::E!#)+
=/!/1/H#/3@#%%D/QC ?8!:61:3!QC (QC view). P/*:1/%@'/36B!/
DQ3)+$/(/11CY,%DG/4?/:
F"$)6"+!/#
-
7/23/2019 3193 Instruction RU e411
139/379
Roche DiagnosticsB-23 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q)
%#R*!#%/Z+63/1%D,IE):!. I3:E!#)+36B:*%:
=:@3?/!G@/%+B.
2 -#G1+3/>#@4B!#6=/A#3*+6=+6*#.
3 e#1/%+3/?6/%/:EK:@+1D/!/#
Load List) %#R*!#%/Z+63/1%D,IE):!. I3:E!#)+36B:*%:
=:@3?/!G@/%+B.
2 TDE/!+3/>V, A3:ED!#6=/A#3#356=+6:*.
NE%,$b"6)b"%"',0:"9,%,%?H:20)$8,D'J7$2L,!2X')/$2/QC (Calib/QC Load List)2777,$!,
:)6"0%2!2""/$)''"$%+JP:)72=2P.
c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2,06.8,6"+,F",D"+%+EY$,00"%+,0%'. A-10.
e >4B=:4'A/%+B@:=:4%+3/45%:, +%F:!1#&++, 61.
: Z=+6:*e#
-
7/23/2019 3193 Instruction RU e411
140/379
Roche DiagnosticsB-24 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q)2.:+"D+-1-'D':'1':"
2 e#1/%+3/3!/E'/1D/!/#
53). B-15 f"D:742"-'
-
7/23/2019 3193 Instruction RU e411
141/379
Roche DiagnosticsB-25 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q)
ProCell/CleanCell.
e >4B=:4'A/%+B@:=:4%+3/45%:, +%F:!1#&++=:R3+16+
-
7/23/2019 3193 Instruction RU e411
142/379
Roche DiagnosticsB-26 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q)
:*%:2%?/%3#!%:
-
7/23/2019 3193 Instruction RU e411
143/379
Roche DiagnosticsB-27 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q)
^2+,!27,=22%#63!. C-30.
5 e#=:4%+3/*:%3/,%/!@+63+44+!:?#%%:,+4+@/+:%+)+!:?#%%:,?:@:,.
6 -/:EK:@+1:@:E#?+35SysWash ?=!:=:!&++100+1. >:E#?53/35 14SysWash *
@+63+44+!:?#%%:,+4+@/+:%+)+!:?#%%:,?:@/, )#4+?#B#**'!#3%:, ?:
+)E/G#%+/!#6=4/6*+?#%+B.
7 TD6'N+3/?%/N%MM=:?/!K%:635*:%3/,%/!#6=:1:H5ME'1#G%DK
=:4:3/%/&, )#*!:,3/*:%3/,%/!*!DN*:,+=:1/63+3//
-
7/23/2019 3193 Instruction RU e411
144/379
Roche DiagnosticsB-28 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q)
?:@:,.
6 8!:3!+3/?%/N%MM=:?/!K%:635*:%3/,%/!#E'1#G%D1=:4:3/%&/1.
7 Z=:1:H5ME'1#G%:
-
7/23/2019 3193 Instruction RU e411
145/379
Roche DiagnosticsB-29 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q)
c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06\X',X)%$,)%Y)
-
7/23/2019 3193 Instruction RU e411
146/379
Roche DiagnosticsB-30 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
Q)
-
7/23/2019 3193 Instruction RU e411
147/379
Roche DiagnosticsB-31 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
-
7/23/2019 3193 Instruction RU e411
148/379
Roche DiagnosticsB-32 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06. +"-Roche $)+%')!2+,0%'. A-15.
O/L"4$/$/23G/+%%'3$%1+%2-;1/J+/+3'C
1 8:@
+%63!'1/%3#. Z4/@',3/?#N+14:*#45%D1=!#?+4#1=:?D=:4%/%+M
@:=:4%+3/45%DK*:%3!:4/,?4#E:!#3:!++.
3 e#
-
7/23/2019 3193 Instruction RU e411
149/379
Roche DiagnosticsB-33 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+4B=:4'A/%+B@:=:4%+3/45%:,+%F:!1#&++:
L,$+,7+,9,%?:)72=22$,!2X',%)')/2$)+%')!"T%#63!. B-104
c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06. +"-Roche$)+%')!2+,0%'. A-15.
c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06. FJ9+)"+,7+,9"+2"$)+%"T+"')/)X',7=)/+,0%'. A-9..
@$/13%'/13-J+3Y-$%($/+%Q-$$/23G/+%%'3$%1+%2-;
Z*#%+!:?#%+/N3!+K-*:@*#!3:A/*64/@'/3?D=:4%B35, =!+)#
:E!#H/%%D1*)#@%/,A#63+#%#4+)#3:!#. T63#?53/*#!3:A*' ?63#%&+M1#*6+1#45%:
j63#%:?*#(QC > Install) .
2 T63#?53/N3!+K-*:@*#!3:A*'?63#%&+M6A+3D?#%+B*#!3:A/*, 6N3!+K-
*:@:1, :E!#H/%%D1 * )#@%/, A#63+ #%#4+)#3:!#. T63#?53/ *#!3:A*' ?
63#%&+M1#*6+1#45%:
-
7/23/2019 3193 Instruction RU e411
150/379
Roche DiagnosticsB-34 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
-
7/23/2019 3193 Instruction RU e411
151/379
Roche DiagnosticsB-35 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+1"1.
-
7/23/2019 3193 Instruction RU e411
152/379
Roche DiagnosticsB-36 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
1 TDE/!+3/QC > Install.
R$+3'/?38QC +-)+/
53). B-23 W2:"-QC > ])+/1%'$/(QC > Install)
2 TDE/!+3/3!/E'/1D,*:%3!:45+)6=+6*#*:%3!:4/,
3 TDE/!+3/3/63, *:3:!D/?DK:3+3/#*3+?+!:?#35 +)6=+6*#*:%3!:4/,.
4 TDE/!+3/V*3+?%D,_/63(Active Test) @4B#*3+?#&++?DE!#%%:4B@/#*3+?#&++#*3+?%:
-
7/23/2019 3193 Instruction RU e411
153/379
Roche DiagnosticsB-37 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+94:--13-$/23G/+%%'3$%1+%2-;
1 -#G1+3/Z3#!3(Start) (
?D=:4%/%+/*#4+E!:?*++*:%3!:4B.
d0!2XE!,/EX',+,,/%)6,%29"0$,.',0:"9,%$,/S%2!2%,(Utility) > H20%"6,(Utility >
System)(H%'. 2/3) > S0%,+)/$2c)$J6"+%2')/,+2.(Documentation Setup) , :'27,/"'_"+22
$,!2X')/$2,/%)6,%29"0$2XJ
-
7/23/2019 3193 Instruction RU e411
154/379
Roche DiagnosticsB-38 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
-
7/23/2019 3193 Instruction RU e411
155/379
Roche DiagnosticsB-39 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+ Z3#3'6(Calibration > Status) . 26=:45)',3/R3:3R*!#%
@4B?DE:!#3/63:?=:)#1/%/, 3#,1#'3'+4+%#!'N/%+MQC.
53). B-26 W2:"-]1"17$Q").3:'
-
7/23/2019 3193 Instruction RU e411
156/379
Roche DiagnosticsB-40 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
-
7/23/2019 3193 Instruction RU e411
157/379
Roche DiagnosticsB-41 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
Individual) .a3:ED:E/6=/A+35K:!:N//*#A/63?:63#3+63+A/6*+K@#%%DK,
?#G%:!/
-
7/23/2019 3193 Instruction RU e411
158/379
-
7/23/2019 3193 Instruction RU e411
159/379
Roche DiagnosticsB-43 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
-
7/23/2019 3193 Instruction RU e411
160/379
Roche DiagnosticsB-44 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
-
7/23/2019 3193 Instruction RU e411
161/379
Roche DiagnosticsB-45 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+-;)%:
-#R*!#%/Z+63/1#(j3+4+3#> Z+63/1#(Utility > System)), )%#A/%+/@4B
j63#%:?*#d3!+K-*:@:?stat/Z3#%@#!3%D/ (Barcode Setting Stat/Routine) @:4G%:
ED35>V.
TC,%21-13-,%L/::3%'/138,%%G/4?/:
TD=:4%/%+/=!:
)0%,+,/!2/,"%0./:)72=2230.
-
7/23/2019 3193 Instruction RU e411
162/379
-
7/23/2019 3193 Instruction RU e411
163/379
Roche DiagnosticsB-47 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
'=!#?4BMH/,6+63/1D. -:1/!=:64/@:?#3/45%:63+ =!+6?#+?#/36B**#G@:1' ID ?:
?!/1B)#
(Work List) ,!#6=/A#3#%%D,?*:%&/=!:
c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06. 8,D'J7$,2',7D'J7$,
-
7/23/2019 3193 Instruction RU e411
164/379
Roche DiagnosticsB-48 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+6@/4#%D.
1 TDE/!+3/Z3#!3(Start) (
-
7/23/2019 3193 Instruction RU e411
165/379
Roche DiagnosticsB-49 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
-
7/23/2019 3193 Instruction RU e411
166/379
Roche DiagnosticsB-50 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
-
7/23/2019 3193 Instruction RU e411
167/379
Roche DiagnosticsB-51 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
-
7/23/2019 3193 Instruction RU e411
168/379
Roche DiagnosticsB-52 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
-
7/23/2019 3193 Instruction RU e411
169/379
Roche DiagnosticsB-53 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
-
7/23/2019 3193 Instruction RU e411
170/379
Roche DiagnosticsB-54 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+1"1.
IEB)#3/45%:'*#G+3/ID N3#3+?#+%:1/!=:)+&++%#'=!#?4BMH/,
6+63/1/.
2 P#6=/A#3#,3/!#E:A+,6=+6:*%#'=!#?4BMH/,6+63/1/.
-
7/23/2019 3193 Instruction RU e411
171/379
Roche DiagnosticsB-55 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
1 -#G1+3/Z3#!3(Start) (
-
7/23/2019 3193 Instruction RU e411
172/379
Roche DiagnosticsB-56 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
%'G%: TDE:!_/63:?(Test Selection) .
53). B-45 W2:"-R?3':O+$1'1"1.*4#?+#3'!D. T?/@+3/ID :E!#)(Sample ID) ?6::3?/363?'MH//=:4/.
4 TDE/!+3/8!/@?#!+3/45%:/P#)E#?4/%+/T*4. (Pre-dilution On) X64+:E!#)/&'G/ED4!#)E#?4/%?!'A%'M.
5 -#G1+3/*%:=*'-:!1#45%#B+4+j1/%5N/%%#B(Normal or Reduced) @4B8!:E+!*#IE!#)(Sample Cup) .
6 TDE/!+3/3!/E'/1:/!#)E#?4/%+/@4B:E!#), /64+%'G%:, ?=:4/6=+6*#
IEi/1IE!#)/P#)E#?4/%+/(Sample Volume/Dilution) .
7 TDE/!+3/3/63, *:1E+%#&+M3/63:?+4+=!:F+4+3/63:?@4B:E!#)?
1#3!+&/3/63:?DK*4#?+N. TDE!#%%D/*4#?+N+3/63:?+=!:F+4/,
:3:E!#G#M36BE/4D1&?/3:1.
8 TDE/!+3/Z:K!#%+35(Save) @4B6:K!#%/%+B?DE:!*+3/63:?.
-
7/23/2019 3193 Instruction RU e411
173/379
Roche DiagnosticsB-57 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
%#63!:,*+:34+A#M36B:33!/E'/1DK, ?%/6+3/%/:EK:@+1D/+)1/%/%+B.
3 TDE/!+3/Z3#!3(%#R*!#%/j64:?+Be#='6*#(Start Conditions) ). Z+63/1#
?D=:4%+3=!:&/66+6K:@%:,=:@
-
7/23/2019 3193 Instruction RU e411
174/379
Roche DiagnosticsB-58 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38
H%,+
1 TDE/!+3/P#E:A//]/63:(Workplace) > TDE:!_/63:?(Test Selection) .
53). B-47 W2:"-R?3':O+$1'1"1.
?!/1B, =!:?/!53/, A3:+1//36B=:@@:%%#4+%++C (?DK:@%:,E'F/!). X64+
%/:EK:@+1:, =:1/63+3/=:@@:%%#4+%+MC.
-
7/23/2019 3193 Instruction RU e411
175/379
-
7/23/2019 3193 Instruction RU e411
176/379
Roche DiagnosticsB-60 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
?6/
-
7/23/2019 3193 Instruction RU e411
177/379
Roche DiagnosticsB-61 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
-
7/23/2019 3193 Instruction RU e411
178/379
-
7/23/2019 3193 Instruction RU e411
179/379
-
7/23/2019 3193 Instruction RU e411
180/379
Roche DiagnosticsB-64 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
1 TDE/!+3/P#E:A//]/63:(Workplace) > TDE:!_/63:?(Test Selection) .
53). B-52 R?3':O+$1'
5 TDE/!+3/8!/@?#!+3/45%:/P#)E#?4/%+/T*4. (Pre-dilution On) X64+:E!#)/&'G/ED4!#)E#?4/%?!'A%'M.
6 -#G1+3/*%:=*'-:!1#45%#B+4+j1/%5N/%%#B(Normal or Reduced) @4B8!:E+!*#IE!#)(Sample Cup) .
c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2,06>0:)!?7)/,+2"62$'):')X2')$+,0%'. A-17.
7 TDE/!+3/3!/E'/1:/!#)E#?4/%+/@4B:E!#), /64+%'G%:, ?=:4/6=+6*#IEi/1
IE!#)/P#)E#?4/%+/(Sample Volume/Dilution) .
-
7/23/2019 3193 Instruction RU e411
181/379
Roche DiagnosticsB-65 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
=:)+&+,.
K%L/::3%'/13-STAT %G/4?%')J+3Y-$%(/:3
1 e#
2 TDE/!+3/S.Stop (I63#%:?*#=/!/%:6#:E!#)&:?), +?D=:4%+3/
Z*#%+!:?#%+/IE!#)&:?.
-
7/23/2019 3193 Instruction RU e411
182/379
-
7/23/2019 3193 Instruction RU e411
183/379
Roche DiagnosticsB-67 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
%#63!:,*+%/3#*+/, *#*3!/E'/36B, %'G%:=!:+)?/63+%/:EK:@+1D/+)1/%/%+B..
3 TDE/!+3/Z3#!3(%#R*!#%/j64:?+Be#='6*#(Start Conditions) ). Z+63/1#
?D=:4%+3=!:&/66+6K:@%:,=:@
-
7/23/2019 3193 Instruction RU e411
184/379
Roche DiagnosticsB-68 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38
H%,+-;)%:
K%L/::3%'/13- STAT %G/4?%'
1 TD=:4%+3/=!:1:.@-2'6"5.
-
7/23/2019 3193 Instruction RU e411
185/379
Roche DiagnosticsB-69 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
-
7/23/2019 3193 Instruction RU e411
186/379
Roche DiagnosticsB-70 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+1"1.
7 TDE/!+3/8!/@?#!+3/45%:/P#)E#?4/%+/T*4. (Pre-dilution On) X64+:E!#)/&'G/ED4!#)E#?4/%?!'A%'M.
8 -#G1+3/*%:=*'-:!1#45%#B+4+j1/%5N/%%#B(Normal or Reduced) @4B8!:E+!*#IE!#)(Sample Cup) .
c!.:)!J9"+2.)X["T2+^)'6,=22:)X"7):,0+)0%2, 06>0:)!?7)/,+2"62$'):')X2')$+,0%'. A-17.
9 TDE/!+3/3!/E'/1:/!#)E#?4/%+/@4B:E!#), /64+%'G%:, ?=:4/6=+6*#IEi/1IE!#)/P#)E#?4/%+/
(Sample Volume/Dilution) .
10 TDE/!+3/3/63, *:1E+%#&+M3/63:?+4+=!:F+4+3/63:?@4B:E!#)?1#3!+&/3/63:?DK*4#?+N. TDE!#%%D/
*4#?+N+3/63:?+=!:F+4/,:3:E!#G#M36BE/4D1&?/3:1.
11 TDE/!+3/Z:K!#%+35(Save) @4B6:K!#%/%+B?DE:!*+3/63:?.
-
7/23/2019 3193 Instruction RU e411
187/379
Roche DiagnosticsB-71 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
53). B-59 f"D:742"'3:"4I'1:.@-2'6"5.
-
7/23/2019 3193 Instruction RU e411
188/379
Roche DiagnosticsB-72 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
!#E:A+16=+6*:1'=!#?4BMH/,6+63/1D.
2 e#
-
7/23/2019 3193 Instruction RU e411
189/379
Roche DiagnosticsB-73 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
1 TDE/!+3/Z3#!3(Start) (
-
7/23/2019 3193 Instruction RU e411
190/379
Roche DiagnosticsB-74 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+3/63:?.
d0!2%'"XJ"%0.+"0$)!?$) STAT_%,%2/)/, /E TDE:! _/63:?(Test
Selection) +?D=:4%BM36B#%#4+)#3:!:1#?3:1#3+A/6*+.
53). B-63 W2:"-R?3':O+$1'
-
7/23/2019 3193 Instruction RU e411
191/379
Roche DiagnosticsB-75 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
5"Q1%-,-('/3+-271%-/4G/'2-13-%G/4?%'
X64+:E!#)/&!#)E#?4B/36B?!'A%'M=/!/@#%#4+):1, ?D1:G/3/%#63:+35+%63!'1/%3
@4B#%%DK(Data Review) .
9(-1+3>3$/?38%G/4?/$/$,-('/3+-271%/4G/'2-11%L%
1 TDE/!+3/P#E:A//]/63:(Workplace) > TDE:!_/63:?(Test Selection) @4B
:3:E!#G/%+B:@%:+1/%%:
>76"'"+2.0%,+
-
7/23/2019 3193 Instruction RU e411
192/379
Roche DiagnosticsB-76 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+
?/!K%/,4/?:,A#63+R*!#%#) @4B:3:E!#G/%+B:*%#IE):!Z+63/1D(System
Overview) .
2 TDE/!+3/I364/G+?#%+/IE!#)&:?(Sample Tracking) @4B:3:E!#G/%+B:@%:+1/%%:
-
7/23/2019 3193 Instruction RU e411
193/379
Roche DiagnosticsB-77 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
D+)2-B3'/13-DG/4?%'(Sample Tracking) ')3)+-:-
1 TDE/!+3/
-
7/23/2019 3193 Instruction RU e411
194/379
-
7/23/2019 3193 Instruction RU e411
195/379
Roche DiagnosticsB-79 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
H%,+
6:E4M@#B=!+R3:1%/:EK:@+1D/1/!D=!/@:63:!:G%:63+.
A
C
V'66'-3
V'66'-1
B V'66'-2
53). B-68 G3)"$1.&'66'-'
#%#4+)#3:!%#A+%#/3+6=:45):?#35=:@@:%1.
-
7/23/2019 3193 Instruction RU e411
196/379
Roche DiagnosticsB-80 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
H%,+:3:E!#G#/36B%#R*!#%/Z+63/1%D,IE):!(System Overview) . -#P+6. B-69,
=:*#)#%#2%?/%3#!%#B:E4#635, 6'*#)#%+/11#!*/!:?=:)+&++)#K?#3A+*#+
=:)+&+M=:@@:%#1 @4B!/#*&+:%%DKBA//*+%#*:%/A%+*:?. 8:@@:%D2 +3
)#=:4%/%D+@4B3:
%#*:%/A%+*:?1:
-
7/23/2019 3193 Instruction RU e411
197/379
Roche DiagnosticsB-81 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
F"7J!?%,%E
@3:'%2C@3)+-:1%L%
DG4%/(System Overview)
(,%G3$3/1/$%1-Q13$3)
D,?334/L"4$3
-/)#
]:G/3/)#
]:G/3/ )#
]:G/3/)#
[/G23?/B -3
V:.5+:?'&I.B4"D:742.
-
7/23/2019 3193 Instruction RU e411
198/379
-
7/23/2019 3193 Instruction RU e411
199/379
Roche DiagnosticsB-83 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
F"7J!?%,%E
53). B-71 W2:"-G34':c"--?@(Data Review) (>1"1.#%%DK(Data
Review) ?%+):33/*'H/
-
7/23/2019 3193 Instruction RU e411
200/379
Roche DiagnosticsB-84 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
F"7J!?%,%E
6 -#G1+3/I31/%#@4B)#*!D3+B:*%#8:+6*IE!#)&:?+?:)?!#H/%+B%#
R*!#%IE):!>#%%DK(Data Review) . TDE!#%%D,:E!#)/&?D@/4B/36B.
b327+/?38-4"27+/+%',%,/?3-1+/:
26=:45)',3/R3'F'%*&+M@4BF+453!#&++=:3+=':E!#)&:?, *:3:!D/?D
K:3+3/=!:61:3!/35, @:*'1/%3+!:?#35+4+!#6=/A#3#35. -#63!:,*#F+453!#=:
'1:4A#%+M TD*4.
b327+/?38-4"27+/+%',%,/?3-1+/:
1 -#G1+3/*%:=*'+453!@4B:3:E!#G/%+B:*%#+453!, +6=:45)'/1:#%%DK(Data Review) .
3 TDE/!+3/T*4. ?:E4#63++453!%#R*!#%/IE):!>#%%DK(Data Review) @4B
#*3+?#&++F+453!#. P/)'453#3DF+453!'M36B?6::3?/363?++6*!+3/!+/1
F+453!#, *:3:!D,?D?DE!#4+.
5/),-Q/+$/34/L"4$/-4"27+/+%',%,/?3-1+/:
I*%:-#63!:,*+>:*'1/%3+!:?#%+B+8!+%3/!#=:)?:4BM3?#1?DE!#35
%'G%'M:=&+M@:*'1/%3+!:?#%+B+R4/1/%3D@4B#?3:1#3+A/6*:, !#6=/A#3*+.
d0!2/E/EX"'2%"8,D'J7$,, 2!2F,0:"9,%$,/8,D'J7$,,%):'2)%$!P9"++)T$)66J+2$,=220
J:',/!.P["T020%"6)T+,W$',+"S0!)/2.8,:J0$,(Start Conditions) , D"+"'2'J"%0.02D+,!?+)"
0))X["+2".
5/),-Q/+$/3234/L"4$/-4"27+/+%',/?3-1+%'
1 TDE/!+3/j3+4+3#(Utility) > Z+63/1#(Utility > System).
2 TDE/!+3/63!. 2/3
3 TDE/!+3/-#63!:,*#>:*'1/%3+!:?#%+B (Documentation Setup) @4B:3:E!#G/%+B
:*%#-#63!:,*#>:*'1/%3+!:?#%+B+8!+%3/!#(Documentation and Printer Setup).
-
7/23/2019 3193 Instruction RU e411
201/379
Roche DiagnosticsB-85 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
F"7J!?%,%E
4 TDE/!+3/:=&+M?:E4#63+j64:?+Be#?/!N/%+B(Completion Conditions) .
5 TDE/!+3/:=&+M?:E4#63+Z:/@+%/%+/68!+%3/!:1(Printer Connection) .
6 TDE/!+3/:=&+M?:E4#63+V?3:1#3+A/6*#BP#6=/A#3*#(Automatic Printout) .
7 -#G1+3/OK @4B6:K!#%/%+B?DE!#%%DK%#63!:/*+)#*!D3+B-#63!:,*#
>:*'1/%3+!:?#%+B(Documentation Setup) .
D,?33%G2/)+3])2%'38O/'-J-138(Completion Conditions)
F,0:"9,%$,
8,D'J7$,
F,0:"9,%$,
/8,D'J7$,
8:64#35:3A/3D%#=!+%3/!.
e#
L,!2X')/$,\X',7=,
L)+%')!?+ET
\X',7"=
STAT\X',7"=
H%,+ IE):!
>#%%DK(Data Review) .
5/),-Q/+$/D+Q-+/,%5-4"27+/+/:
1 TDE/!+3/3!/E'/1D/@#%%D/?P#E:A//]/63:(Workplace) > IE):!>#%%DK
(Data Review) =/!/@!#6=/A#3*:,+=!:61:3!:1R3:
-
7/23/2019 3193 Instruction RU e411
202/379
Roche DiagnosticsB-86 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
F"7J!?%,%E
53). B-74 /2:"-V+E"19"3'E+D'K+$1"(Workplace Print)
4 TDE/!+3/I3A/3=:P/)'453#3#1(Result Report) +)6=+6*#b4/1/%3DP#E:A/
-
7/23/2019 3193 Instruction RU e411
203/379
Roche DiagnosticsB-87 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
Q)0%-):"',=2)++)"J:',/!"+2"j@#4B,3/@:*'1/%3+!:?#%%D/ :E!#)&D@4B?D6?:E:G@/%+B@:=:4%+3/45%:DE59-$(System Overview) (h+@P#E:A/ IA+63*#>#%%DK=::E!#)(Sample Data Clear) .
2 TDE/!+3/j@#4+35T6/(Delete All) @4B'@#4/%+B@#%%DK=::E!#).
jB-(1-'1%-%G)2"B3'/13-
8/!/@)#?/!N/%+/163#%@#!3%:,!#E:3D, ?#G%:'@:63:?/!+36B, A3:?D=:4%/%D?6/
%/:EK:@+1D/@/,63?+B:E64'G+?#%+B. >:=:4%+3/45%:*63#%@#!3%:1'@%/?%:1'
:E64'G+?#%+M, 3#*G/64/@'/3?D=:4%B35@!'
-
7/23/2019 3193 Instruction RU e411
204/379
Roche DiagnosticsB-88 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
NE$!P9"+2",+,!27,%)',
TC$2PQ-13-/1/234/+%/
8:64/)#?/!N/%+B63#%@#!3%:,!#E:3D+?D=:4%/%+B?6/H20%"6,(Utility > System).
TC$2PQ-13-/1/234/+%/
1 j63#%:?+3/:=/!#&+:%%D,=/!/*4MA#3/45?=:4:G/%+/TD*4. I3:E!#)+36B:*%:Z:%(Sleep) (C/)@/,63?+/).
53). B-75 G2-']'-(Sleep)
N )$+"H)+(Sleep) +"/EX2',T%"NE$!P9"+2", "0!2/E+"Y)%2%")%$!P9,%?/0"^J+$=22
2$)6:)+"+%E,+,!27,%)',.
Q'2/EX)'"NE$!P9"+2"Q2%,+2.:))_2X$", /E$!P92%"D!,/+ET%J6X!"':2%,+2.,
:)
-
7/23/2019 3193 Instruction RU e411
205/379
Roche DiagnosticsB-89 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 6 K%')-(1-'1/8V$),2"/+/?38
NE$!P9"+2",+,!27,%)',
1 I3*!:,3/6+==/!%D,H+3:*, %#@#?+?%#E/4'M1/3#44+A/6*'M:E4#635
%#?/!K', *#*=:*#)#%:%#64/@'MH/1!+6'%*/, @:?D6?:E:G@/%+B)#H/4*+.
A
A _"*5.1+46+$96)='12:?1.=.).4"2:?1.=$.&&+:-'D'T.12"
53). B-76 G12:'B1+$.&&+:-?BT.1'2
2 e#*!:,3/*!DN*+%#E'3D4*#KProCell +CleanCell.
53). B-77 f"2:'B1+2:?>2.ProCell/CleanCell
-
7/23/2019 3193 Instruction RU e411
206/379
Roche DiagnosticsB-90 5"$%'%()+'%%,-/+%/ T-)381.0
6 K%')-(1-'1/8V$),2"/+/?38 /1/234/+%cobas e 411
NE$!P9"+2",+,!27,%)',
3 e#*!:,3/H+3:*6+==/!#, %#@#?+?%#E/4'M1/K#%+A/6*'M:E4#635%#?/!K',
=:*#?D%/'64DN+3/H/4A:*, '*#)D?#MH+,%#)#*!D3+/)#H/4*+.
K%'-$3,3,%21%:'C$2PQ-133,3+/138
X64+ #%#4+)#3:! E'@/3 ?D*4MA/% @:45N/ 6/1+ @%/,, ?#G%:
6::3?/363?'MH+1 :E!#):1 =:@
-
7/23/2019 3193 Instruction RU e411
207/379
Roche DiagnosticsB-91 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 7 @,-?3/271C-%,-/?33: =/$?...
@,-?3/271C-%,-/?33: =/$?...
TR3:,
\#*%#)%#A#35=:)+&++*#4+E!#3:!:?+*:%3!:4/,........................................... 104
\#*'63#%#?4+?#35+:=!/@/4B35*:%3!:4+Roche...................................... ...... 106
\#*'63#%#?4+?#35+:=!/@/4B35%/Roche *:%3!:4+ ...................................... 107
\#*!/@#*3+!:?#35*:%3!:45%D/)%#A/%+B ........................................................ 109
\#*)#=!#N+?#35 QC @4BE'3D4*+?!/G+1/:G+@#%+B................................... 110
\#*:31/%B35)#@#%+/=/A#3+ ...................... ............................................. ...... 111
\#*!#6=/A#3D?#35/G/@%/?%D,:3A/3I364/G+?#%+/Z+\#*+)1/%B35%#63!:,*+3/63:? .......................................................................... 116
\#*+)1/%B35%#63!:,*+*#4+E!:?*+ .................................................................. 118
\#*+)1/%+35!/G+1@+6*#:E!#)&:? ................................................................. 119
-
7/23/2019 3193 Instruction RU e411
208/379
Roche DiagnosticsB-92 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 7 @,-?3/271C-%,-/?33: =/$?...
-
7/23/2019 3193 Instruction RU e411
209/379
Roche DiagnosticsB-93 5"$%'%()+'%%,-/+%/ T-)381.0
/1/234/+%cobas e 411 7 @,-?3/271C-%,-/?33: =/$?...
\X7)'
DG4%
Z/*&++?R3:,/3#4+=:!#)4+A+M1/G@'@+6*:?:,+N3#3+?%:,6+63/1:,, 61. ?c20$)/,.2
_%,%2/+,.020%"6E+,0%'.B-5.
-
7/23/2019 3193 Instruction RU e411
210/379
Roche DiagnosticsB-94 5"$%'%()+'%%,-/+%/ T-)381.0
7 @,-?3/271C-%,-/?33: =/$?... /1/234/+%cobas e 411
L,$20:)!?7)/,%?W%2$"%$2_%'2Y-$)=/$3),%274%'/+7V+3$-+$3J+3Y-$%(%'(28,%G3%$3-:$%)+-;
P#)1/!+!#)1/H/%+/N3!+K-*:@R3+*/3:*%#*:%3/,%/!#K@4B:E!#)&:?,
*#4+E!#3:!:?+*:%3!:4/,, @:4G%::3?/A#35:=!/@/4/%%D1 6=/&+F+*#&+B1.
Z*#%/!N3!+K-*:@:?1:G/3%/A+3#35R3+*/3*+=!+%/6:E4M@/%++@#%%DK
'64:?+,.
9),%274%'/13-J+3Y-$%(V+3$-+%$1/,%G3$/Y%G/4?%', 3-:$%)+8Y
(28$/23G/+%%'3$%1+%2-;
1 jE/@+3/65, A3:!#)1/!DN3!+K-*:@R3+*/3:*3#*+/, *#*'*#)#%D%#!+6. B-78.
A M.:.-"/1.2+12"(16 55
5.-.575) C _+B1:")9-"=4'-"
(5555.-.575)
E _+B1:")9-"=4'-"(5555.-.575)
B M.:.-">1:.@-2'6"(1255
5.-.575) D f'-">1:.@-2'6"(50 55
5"2$.5756)=10055&:'3.:'2; 38
555"2$.5756)=7555&:'3.:'2)
O(&. B-78 P#)1/!DN3!+K-*:@R3+*/3:*@4B=!:E+!:*+/1*:63/,
2 >4B=!:E+!:*:E!#)&:?, =:1/63+3/N3!+K-*:@R3+*/3*+?6::3?/363?++?
6::3?/363?++6: